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CPEB proteins are a family of four mRNA-binding protein paralogs that regulate the 
synthesis of proteins required for a number of important cellular process.  CPEB proteins act by 
binding to the CPE elements present on the 3’UTR of target mRNAs.  One process regulated by 
CPEB is synaptic plasticity and long-term memory. A feature of the some CPEB members is their 
sequence similarity to a unique class of proteins, known as prion-like proteins that use distinct 
conformation states to regulate their function.  It has been hypothesized that mammalian CPEB 
proteins employ a similar mechanism to induce the stable changes in synaptic activity required for 
memory maintenance. Previous studies implicated the CPEB family member, CPEB2, in synaptic 
plasticity and long-term memory. However, the function of the CPEB2 prion-like sequence is still 
unknown and this thesis evaluates the function of CPEB2 prion-like sequence in translation 
regulation and memory. The initial experiments demonstrate CPEB2 forms SDS-resistant 
oligomers in neurons.  We generated an isoform specific CPEB2 knockout mouse that removed 
exon 1 and the prion-like sequence.  We tested the ability of this knockout mice to form oligomeric 
structures, regulate translation, and form long-lasting memory.  The results show that the CPEB2 
isoform containing the prion-like sequence regulates expression of key memory molecules, and is 
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Chapter 1: General Introduction 
 
Introduction 
Memory is the ability of organisms to retain and use acquired information.  A fundamental 
goal of neuroscience is to understand the mechanisms underlying memory.  In 1885, Hermann 
Ebbinghauss proposed that there are two different types of memories, short-term memories (STM) 
and long-term memories (LTM) (Ebbinghaus, 1885).  Since this initial hypothesis, we have learned 
that these two distinct types of memories involve a complex cellular machinery responsible for 
interpreting environmental and internal stimuli and weighing the necessity of storing and 
maintaining this information.  Central to our understanding has been establishing that neurons and 
their connections to other neurons, synapses, are the cellular location where memories are stored.  
Like memory, the strength of synapses can be increased or decreased, referred to as synaptic 
plasticity.  Decades of work have established that synaptic plasticity is fundamental to memory, 
however, many unanswered questions still remain.  One highly active area of research is how 
synaptic plasticity can encode different types of memory, such as short and long-term memory.  
The focus of this thesis, are the mechanisms required for memory consolidation, that is, the 




Neurons communicate with each-other through synapses, structure in which the axon 
terminal of a presynaptic neuron connects to the dendritic of a postsynaptic neuron.  The most 
common type of synapse is a chemical synapse.  Chemical synapses are composed of a 
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presynaptic axon terminal, synaptic cleft, and a post-synaptic spine.  The presynaptic axon 
terminal, or synaptic bouton, contains neurotransmitters enclosed in synaptic vesicles.  
Communication across the synapses occurs through the process of synaptic transmission.  There 
are two major classes of synaptic transmission, excitatory and inhibitory.  This thesis focuses on 
excitatory transmission.  Excitatory synaptic transmission occurs when the presynaptic neuron is 
activated and upon reaching its threshold potential generates an action potential, a self-sustaining 
wave of electrochemical membrane depolarization. The action potential travels along the axon of 
the presynaptic cell and invades the axon terminal at the synapse.  With the depolarization of the 
invading action potential, the synaptic vesicles fuse to presynaptic membrane and release their 
neurotransmitters into the synaptic cleft.  Once released into the synaptic cleft, the 
neurotransmitters bind to the membrane receptors on the postsynaptic spine or nearby dendrites.  
In excitatory chemical transmission, the neurotransmitters bind to ligand-gated ion channels 
resulting in opening of the channels and an influx of ions into the postsynaptic cell.  The ions 
depolarize the local transmembrane potential and result in excitatory postsynaptic potential 
(EPSP).  With a sufficiently large or with successive EPSPs, the probability increases that a post-
synaptic neuron fires an action potential 
Synaptic strength is not fixed. Synaptic strength can be modulated through a mechanism 
known as synaptic plasticity.  Synaptic plasticity is a widely studied phenomenon and is 
considered to be one of the most fundamental mechanisms underlying both learning and memory 
formation.  Synaptic plasticity can modulate the strength of synapses for both short (short-term 
plasticity) or long periods of time (long-term plasticity). For long-term plasticity, there are two 
distinct types of synaptic plasticity, synaptic potentiation (LTP) and long-term depression (LTD) 
(Mayford, Siegelbaum, & Kandel, 2012).  Each results in long-lasting changes at the synapse and 
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alters its response to subsequent stimuli.  Following LTP, an excitatory synapse responds with 
greater activation to the same presynaptic input.  LTP has two phases. The first, early phase LTP 
(E-LTP), is induced by depolarization of the post-synaptic membrane.  The depolarization results 
in the unblocking of the N-methyl D-aspartate receptor (NMDA) and allows Ca2+ entry through 
the NMDA channel (Kumar, 2011).  The influx of intracellular Ca2+ activates a number of 
kinases that induce local, short-term changes in the synapse primarily through the activation of 
Ca2+/calmodulin dependent protein kinase (CaMKII), protein kinase C (PKC), and tyrosine 
kinase (Kandel, Dudai, & Mayford, 2014).  When activated during E-LTP, CAMKII and PKC 
phosphorylate AMPA receptors (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) that 
increase the likelihood of AMPA receptors opening and/or initiate the insertion of additional 
AMPA receptors into the synaptic membrane (Boehm, Ehrlich, Hsieh, & Malinow, 2006; 
Lisman, Malenka, Nicoll, & Malinow, 1997). Both of these changes result in a larger post-
synaptic response to the same synaptic input.  AMPA receptors are one of the main excitatory 
glutamatergic receptors, and when their activity is enhanced via CAMKII or PKC 
phosphorylation or increased in number, the synapse will generate a larger post-synaptic 
response.  
The second phase, late LTP (L-LTP), is initiated by persistent activation of post-synaptic 
kinases initially activated during E-LTP (Kumar, 2011).  For the transition from early to late 
LTP to occur, the levels of synaptic cAMP must increase and cAMP-dependent protein kinase A 
(PKA) must be activated.  Once activated, PKA phosphorylates p42 Mitogen-Activated Protein 
Kinase (MAPK). Both PKA and MAPK translocate to the cell nucleus where they either directly 
(PKA) or indirectly (MAPK) activate the transcription factor cAMP response element-binding 
protein (CREB) (Bacskai et al., 1993; Martin, Michael, et al., 1997).  CREB phosphorylation 
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induces the transcription a subset of genes required for formation long-term potentiation and 
memory.  Of the large number of genes CREB regulates, three are critical for stabilizing LTP: c-
fos, activity regulated cytoskeleton-associated protein (Arc), and brain-derived neurotrophic 
factor (BDNF) (West, Griffith, & Greenberg, 2002).  Activation of these genes results in the 
synthesis of synaptic components required for strengthening synapses, promoting synaptic 
growth, and inducing the formation of new synapses (Alberini & Kandel, 2014; Miyamoto, 
2006). 
 
Local Protein Synthesis 
 
Short-term plasticity depends on rapid but easily reversible post-translational 
modifications in the synapse. However, long-term plasticity requires both transcription and 
translation. Identification that CREB dependent-transcription regulated long-term plasticity 
correlated with previous findings that demonstrated protein synthesis is required for the 
formation of L-LTP (U. Frey, Krug, Reymann, & Matthies, 1988; Krug, Lossner, & Ott, 1984).  
For example,  in rat brain hippocampal slices, adding the protein synthesis inhibitor, anisomycin, 
throughout LTP induction blocks LTP formation (U. Frey et al., 1988).  Further experiments 
explored which phases of LTP are dependent on transcription and translation by adding protein 
synthesis or transcription inhibitors during LTP.  From these experiments, it emerged that protein 
synthesis is required for E-LTP and L-LTP, but transcription is only necessary for L-LTP.  These 
studies established two phases of plasticity: an early phase dependent on protein synthesis and a 
late phase dependent on protein synthesis and transcription.  Memory also requires protein 
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synthesis, as memory formation can be blocked by injection of protein synthesis inhibitors are 
injected into mouse hippocampus and temporal cortex (Flexner, Flexner, & Stellar, 1963). 
How does protein synthesis regulate the formation of long-term potentiation and 
memory?  An answer to this question came about from experiments demonstrating that L-LTP 
could be elicited by local application of brain-derived neurotrophic factor (BDNF) or 
neurotropin-3 (NT3), protein synthesis-dependent neurotropic growth factors (Kang & Schuman, 
1996). These observations indicate that local L-LTP can be experimentally induced at the 
dendrites and/or synapse with these compounds.  The LTP produced by BDNF and NT3 was 
similar to that induced by cAMP analogs, the established transcriptional CREB pathway, 
implying similar mechanisms of actions. However, additional experiments determined the 
precise location of the protein synthesis critical for L-LTP induction.  Kang and Schuman 
demonstrated that LTP can be induced in synapses and dendrites physically isolated from the 
soma (Kang & Schuman, 1996). This LTP still requires protein synthesis.  Martin et al used a 
system of a sensory neuron with a bifurcated axon projecting to two motor neurons that were 
physically separated.  Local LTP is induced in a single branch by application of five serotonin 
pulses.  If protein synthesis inhibitors are applied only to the induced branch, L-LTP formation is 
blocked (Martin, Casadio, et al., 1997).  Both experiments support the concept that the synthesis 
of macromolecules required for L-LTP occurs in either the activated synapse or supporting 
dendrite.  Because both ribosomes and mRNA are present in dendrites and synapses (Fass & 
Steward, 1983; Steward & Fass, 1983; Steward & Levy, 1982), this cellular machinery is likely 





Synapse Specific Activation and “Synaptic Tags” 
  
Induction of L-LTP requires persistent post-synaptic depolarization, activation of several 
kinases, a transcriptional cascade in the nucleus, and local protein synthesis.  Nevertheless, it is 
well known that L-LTP occurs specifically at the originally activated synapse.  This led to the 
hypothesis that neurons have a mechanism of marking or recognizing the synapse that requires 
the local protein synthesis.  This concept of a “synaptic tag” was first tested by Frey and Morris 
using rat hippocampal slices (U. Frey & Morris, 1997).  These investigators observed that if LTP 
is induced in one set of synapses, a subthreshold stimulus provided within a certain time 
window, that by itself would not produce LTP, can induce LTP in a separate set of synapses in 
the same dendritic compartment. LTP formation at either set of synapses can be inhibited if 
protein synthesis inhibitors are added before either stimulation. However, a novel finding was 
discovered when protein synthesis inhibitors were added after a 35-minute delay to same set of 
excitatory synapse on pyramidal neurons. The delayed addition of protein synthesis inhibitors 
did not prevent the induction of L-LTP to the first set of synapses.  With protein synthesis 
completely inhibited, a separate synapse in the same cell was activated with a reduced stimulus 
that normally would induce only E-LTP. Intriguingly, in the absence of protein synthesis, the 
synapse subjected to reduced stimulation also established L-LTP.  This suggests that the proteins 
synthesized in response to the first input, allows formation of L-LTP by the second input (S. 
Frey, Morris, & Petrides, 1997; Kelleher, Govindarajan, & Tonegawa, 2004).  This supports the 
hypothesis that the weak stimulation generates a local “synaptic tag” capable of recruiting the 
needed synaptic plasticity proteins to induce L-LTP at the second synapse.  
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The synaptic tag phenomenon was also investigated in Aplysia, using a neuron with a 
bifurcating axon and two synapses.  In this system, applying five puffs of serotonin to one of the 
synapses induces L-LTP and a single puff induces E-LTP (Martin, Casadio, et al., 1997).  When 
five puffs of serotonin are applied to a synapse on one branch and one puff to the synapse on the 
separate branch of the same neurons, L-LTP is induced at both synapses.  As observed in slice 
cultured hippocampal neurons, activation of local synaptic “tags” are sufficient to induce L-LTP. 
However, in the Aplysia experiment the synapses are separated by approximately 500 µm on 
different axonal branches and suggests the mRNAs produced by transcription are transported to 
every synapse in a neuron where the mRNAs remain dormant until a “synaptic tag” is activated.   
The process of synaptic tagging is temporally complex.  Casadio and Kandel established 
that marking the synapse is a two-phase process, similar to LTP, by repeating the branching axon 
experiments in Aplysia, but using an extended timeline.  In the presence of protein synthesis 
inhibitors, L-LTP can be established at 3-4 hours post-induction at the second synapse, however 
L-LTP cannot maintained at 72 hours (Casadio et al., 1999).  This suggests that during the first 
“induction” the synapse is tagged and allows plastic changes to occur.  This early, protein-
synthesis independent phase is likely due to the recruitment of pre-made proteins to the synapse.  
The later phase involves a second protein synthesis-dependent tag required for the maintenance 
of L-LTP.  Therefore, synaptic tag function involves two steps for the induction and maintenance 
of LTP: 1) the tag resides in the synapse and synaptic activation captures essential pre-made 
synaptic plasticity proteins, and 2) the tag resides in the synapse and synaptic activation regulates 
the translation of locally retained mRNAs required for the maintenance of plasticity.  To 
determine the nature of the protein synthesis-dependent tags, researchers worked to identify 




Cytoplasmic Polyadenylation Binding Proteins  
 
Local protein synthesis-dependent LTP and protein synthesis-dependent “synaptic tags” 
require mRNA translation in neuronal dendrites and synapses.  This requires two important 
components: 1) local collections of mRNA, and 2) translation of specific dormant mRNAs at the 
synapse.  Before addressing synaptic translation, it is useful to review how mRNA translation is 
regulated inside the cell.  At the global level, ribosomes or mRNA binding protein can promote 
or inhibit translation. In addition to protein, non-coding RNA , such as microRNA can also 
regulates translation.  The mechanisms include inducing cleavage of mRNA, destabilizing 
mRNA, or directly interfering with mRNA translation.  
Increasing protein translation can also involve altering the mRNA level, by enhancing or 
reducing the stability of a transcript.  The mRNA level can be regulated in the nucleus as a part 
of quality control. This occurs predominantly inside the nucleus, where generated mRNAs 
undergo splicing, 5’ cap formation, and polyadenylation. RNA splicing involves a series of 
reactions to remove the intronic sequences to generate a mature messenger RNA from a nascent 
precursor messenger RNA.  Subsequently, the 5’ capping of the mature mRNA adds a 7-
methlguanylate cap to the 5’ end.  The key functions of the 5’ cap is to promote the nuclear 
export of the mRNA, protect the mRNA inside the cytoplasm, and promote translation by 
binding to eukaryotic translation initiation factor 4F complex, which recruits the 40S ribosome to 
the transcript.  In the cytoplasm, where translation takes place, mRNA stability is control by the 
3’ and 5’ untranslated regions. 
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A key mechanism in mRNA transport, stability and translation is polyadenylation that 
modifies the 3’ tail of mRNA by adding multiple adenosine monophosphates.  The poly(A) tail is 
a critical regulator of nuclear export, mRNA stability, and translation (Sachs, Sarnow, & Hentze, 
1997). The poly(A) tail consist of A repeats that can be up to 200 nucleotides long and are part of 
the 3’ UTR regulation of protein translation.  Intriguingly, polyadenylation could be a 
mechanism the cell uses to alter the stability and translational activity of particular mRNAs in a 
stimulus-dependent manner (Richter, 1999; Salles, Lieberfarb, Wreden, Gergen, & Strickland, 
1994).  While generalized polyadenylation occurs inside the nucleus and is critical for nuclear 
export and stability, specific transcripts contain an additional sequence in the 3’ UTR that allows 
for further regulation.  This is a U-rich sequence with the consensus structure of UUUUUUAU, 
known as cytoplasmic polyadenylation element (CPE), and was first identified in the Xenopus 
oocyte (McGrew, Dworkin-Rastl, Dworkin, & Richter, 1989).   
The function of CPEs was first described in detail by McGrew et al., who removed the 
CPE from 3’ UTR of the gene G10 in Xenopus, and found that, unlike wild-type, the mutant 
transcript was not polyadenylated or expressed. (McGrew et al., 1989).  This work established 
that CPEs are critical for gene expression by inducing cytoplasmic polyadenylation and thereby 
promoting translation.  Later studies demonstrated how CPEs are used to bi-directionally control 
translation of cytoplasmic dormant mRNAs during oocytes maturation in a hormone-stimulus 
dependent manner. CPE sequence is bound by the protein, cytoplasmic polyadenylation element 
binding protein (CPEB1) and CPSF (cleavage and polyadenylation specificity factor), and 
together they transport transcripts to the cytoplasm (Lin, Evans, Shen, Xing, & Richter, 2010).  
Inside the cytoplasm, CPEB1 bound to CPE forms a complex with CPSF, cytoplasmic poly(A) 
polymerase Gld-2, a scaffolding protein Symplekin, and deadenylating enzyme poly(A) 
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ribonuclease (PARN) (Barnard, Ryan, Manley, & Richter, 2004; J. H. Kim & Richter, 2006; 
Villalba, Coll, & Gebauer, 2011).  This RNA-binding complex can either repress or activate 
translation dependent upon phosphorylation of CPEB1.  In the complex’s basal and repressed 
state, CPEB1 is dephosphorylated and PARN binds to CPEB1 and continually deadenylates and 
silences the transcript.  mRNAs bound to unphosphorylated CPEB1 bind Maskin, which interacts 
with eukaryotic factor 4E (eIF4E) and inhibits formation of the translation initiation complex, 
also silencing the transcript (Minshall, Reiter, Weil, & Standart, 2007; Stebbins-Boaz, Cao, de 
Moor, Mendez, & Richter, 1999).  As the oocyte begins to age, progesterone is released and 
induces CPEB1 phosphorylation.  This results in 1) increasing interaction between CPEB1 and 
CPSF, 2) dissociating PARN from the RNA-binding complex, and 3) reducing the affinity 
between CPEB1 and Maskin by removing its inhibitory constraint (Cao & Richter, 2002; J. H. 
Kim & Richter, 2006; Mendez, Murthy, Ryan, Manley, & Richter, 2000; Stebbins-Boaz et al., 
1999).  As a result, the activated complex enables the polyadenylation of the mRNA by Gld-2 
(Barnard et al., 2004). These findings established a regulatory mechanism inside the cell in 
which CPEB1’s activation state regulated the stability and translation of CPE genes. These 
findings also provided a potential means by which expression of mRNAs in other tissues could 
be controlled, including in synapses. 
 
CPEB in the Nervous System Regulates Synaptic Growth and Synaptic Plasticity: 
 
Although CPEB1 was discovered in oocytes, an initial study showed that in the mouse 
brain, CPEB1 is expressed in synapses and binds to and regulates mRNAs containing CPEs in 
their 3’ UTR (L. Wu et al., 1998).  As a consequence of CPEB1’s unique role as an activator and 
	
	 11	
repressor of cytoplasmic translation and the requirement of neurons for local mRNA translation, 
it was hypothesized that CPEB1 may regulate synaptic protein translation. One of the mRNA 
transcripts regulated by CPEB1 is Ca2+ /calmodulin-dependent protein kinase II (CaMKII), a 
kinase necessary for synaptic plasticity and the formation of long-term memory (Giese, Fedorov, 
Filipkowski, & Silva, 1998).  When synapses are stimulated with glutamate, Aurora kinase 
phosphorylates CPEB1 and induces polyadenylation of CaMKII (Huang, Jung, Sarkissian, & 
Richter, 2002).  This work and others demonstrated CPEB1-mediated polyadenylation controls 
translation in an activity-dependent manner in mammals (Drisaldi et al., 2015; Huang, Kan, Lin, 
& Richter, 2006; Lai et al., 2016; Lu, Yeh, & Huang, 2017; Turimella et al., 2015).  The CPEB-
like protein in Apylsia, apCPEB, can be induced by synaptic activity (Si, Giustetto, et al., 2003).  
Similar to CPEB1 in mammals, activated apCPEB polyadenylates CPE containing mRNAs at the 
synapse.  In Drosophila Melanogaster, the CPEB orthologue, Orb2, binds to a number of targets 
required for growth and synapse formation including: 1) neuroligin, a postsynaptic adhesion 
component, 2) synaptobrevin, a protein required for synaptic vesicle exocytosis, and 3) tequila, a 
serine protease that reorganizes synapses (Mastushita-Sakai, White-Grindley, Samuelson, Seidel, 
& Si, 2010).  Using a cell-based translational assay, it was shown that these three targets are 
translationally regulated by Orb2, further establishing that synaptic growth is regulated by 
CPEB. 
Therefore, CPEB1 is activated in a stimulus dependent-manner, it regulates translation at 
synapses, and a subset of CPEB1 targets are related to synaptic plasticity. This raised the 
possibility that CPEB is essential for synaptic plasticity.  To address this question, Si et al., 
examined in detail the role of apCPEB in Aplysia, using the bifurcated axon model.  When 
serotonin puffs are applied selectively to synapses on an isolated branch, apCPEB becomes 
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activated and F-actin is polyadenylated (Si, Giustetto, et al., 2003). Interestingly, when 
transcriptional or translational inhibitors are added during the stimulation, apCPEB activation is 
independent of transcription, but requires protein synthesis.  To show that activation of apCPEB 
is necessary for L-LTP, apCPEB expression was inhibited by applying an antisense 
oligonucleotide to apCPEB. When apCPEB is inhibited, stimulation can induce E-LTP but not 
stable L-LTP.  To understand when apCPEB is critical for synaptic plasticity, apCPEB was 
inhibited during the two stages of L-LTP; 1) the stabilization stage consisting of the first 72 
hours after LTP induction requiring local synaptic protein synthesis, and 2) the maintenance 
stage consisting of the post 72 hours requiring local synaptic growth (Miniaci et al., 2008).  
Inhibiting apCPEB after 24 hours or 72 hours blocked the stabilization of L-LTP and synaptic 
growth. Therefore, CPEB translational regulation appears critical for both the stabilization and 
maintaining the growth of local synapses.  
 
CPEB in Mammals and its Role in Long-Term Memory 
 
Most studies detailing CPEB function use model organisms and systems amendable to 
studying individual synapses.  However, given the hypothesized fundamental role for CPEB in 
synaptic plasticity, the next question was whether or not CPEB is critical for the formation of 
long-term memory?  To address this, question researchers turned to murine models.  Four 
different CPEB family members, CPEB 1-4, have been identified in mammals.  Based on amino 
acid sequence similarity, the four members are divided into two groups: CPEB1 and CPEB2-4 
(Theis, Si, & Kandel, 2003).  Each CPEB has an N-terminal regulatory domain followed by two 
C-terminal RNA recognition motifs and a zinc finger (ZnF).  CPEB1 has been the species of the 
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most intensive study as detailed above. Relatively less is known about CPEB2-4.  However, due 
to CPEB1 and apCPEB role in synaptic plasticity, recent efforts have focused on understanding 
the function of the other family members.  The goal of these mammalian studies is to determine 
if CPEB1-4 are critical for long-term memory.  The main approach has been to generate 
knockout mice of each family member and assess synaptic plasticity and long-term memory 
formation. Detailed below is what we have learned from these studies by gene. 
 
CPEB1:   
The first gene to be removed from the mouse genome was CPEB1.  Surprisingly, these 
mice exhibit only a modest reduction in some forms of LTP (Alarcon et al., 2004).  CPEB1 
knockout (CPEB1 KO) mice form normal long-term memories, but do show impairments in 
memory extinction (Berger-Sweeney, Zearfoss, & Richter, 2006).  These results were somewhat 
paradoxical to the other forms of mammalian CPEB and Drosophila CPEB, in which 
manipulation of results in more dramatic deficits in LTP and long-term memory (discussed 
below). Interestingly, CPEB1 likely regulates global changes inside the neurons. In CPEB1 KO 
mice, growth hormone levels are dramatically decreased in the nervous system (Zearfoss, 
Alarcon, Trifilieff, Kandel, & Richter, 2008). Growth hormone induces LTP in hippocampal 
slices (Mahmoud & Grover, 2006).  While growth hormone is not a CPEB1 target, a significant 
transcription factor c-jun, is a CPEB1 target and c-jun regulates growth hormone expression.  
These observations demonstrate that CPEB1 has multiple actions that include transcription 
changes and long-term synaptic changes. Thus, it has been suggested that CPEB1 regulate 





CPEB2 was discovered in mouse germ cells.  It shares the most homology with CPEB3 
and CPEB4 (Kurihara et al., 2003).  Expressed in the brain (Hagele, Kuhn, Boning, & 
Katschinski, 2009; Theis et al., 2003), CPEB2 interacts with previously identified mRNAs 
containing CPE elements including B-catenin and CAMKII.  This suggests CPEB2 functions as 
a regulator of translation (Turimella et al., 2015). Another study generated a CPEB2 Cre 
recombinase global knockout (CPEB2 KO) by flanking exons 3-5 with LoxP sites. Of the entire 
CPEB family, only CPEB2 KO mice die shortly after birth when CPEB2 is removed from all 
tissues (Lai et al., 2016).  At the prenatal stage, CPEB2 KO mice have hyper-activation of 
parasympathetic cholinergic neurons that results in fatal bronchoconstriction. These mice also 
reported to have increased levels of choline acetyltransferase (ChAT), the enzyme responsible 
for the synthesis of neurotransmitter acetycholine. The increase in ChAT correlates with the 
hyper-activation of cholinergic neurons. Further, it was demonstrated CPEB2 binds to and 
represses the translation of ChAT in a Neuro-2a neuroblastoma cell line.  This result was 
supported by an RNA immunoprecipitation experiment that revealed ChAT mRNA binds to 
CPEB2 protein (Lai et al., 2016).  Together these findings suggest CPEB2 acts as a translational 
repressor in the parasympathetic nervous system.  However, because the global knockout of 
CPEB2 is lethal in the perinatal stage, it is not possible to assess synaptic plasticity or behavior 
in these animals.   
To address the role of CPEB2 in plasticity and memory, an alternative approach restricted 
the excision of CPEB2 by expressing Cre recombinase only in excitatory neurons of the cerebral 
cortex, amygdala, and hippocampus (Lu et al., 2017).  The restricted excision CPEB2 conditional 
knockout (CPEB2 cKO) results in normal development but impaired long-term potentiation and 
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disrupted long-term memory.  The CPEB2 cKO also exhibit a significant increase in the number 
of immature spines and a decrease in surface expression of AMPARs.  The authors associated 
the decrease in AMPARs with an increased expression of the GRIP-associated protein 1 
(GRASP1). GRASP1 regulates the endosomal recycling of AMPARs receptors through its 
association with glutamate receptor-interacting protein 1 (GRIP1) by coupling the GRASP1-
GRIP1 complex to endosomes (Hoogenraad et al., 2010). CPEB2 was shown to regulate the 
translation of GRASP1, using a firefly luciferase reporter assay in which firefly 3’UTR was 
replaced with the 3’UTR of GRASP1. Firefly luciferase levels increase when expressed in the 
presence of CPEB2 relative to GFP (Lu et al., 2017).  This study established CPEB2 as a 
translation regulator required for long-term plasticity and long-term memory. 
 
CPEB3: 
 CPEB3 is second most studied CPEB family member behind CPEB1.  Early studies 
demonstrated that CPEB3 expression is upregulated in both the mouse hippocampus and cultured 
hippocampal neurons after stimulation, establishing CPEB3 as a strong candidate for the 
activity-dependent synaptic tag (Fioriti et al., 2015; Theis et al., 2003).  Likewise, CPEB3 shares 
a number of sequence similarities with apCPEB, as discussed below.  Two approaches have been 
used to remove CPEB3 from the mouse genome.  The first approach generated a global 
knockout.  Surprisingly, these mice displayed normal synaptic plasticity and actually performed 
better in memory-related tasks (Chao et al., 2013).  The second, more precise approach, 
selectively removed CPEB3 in the forebrain (the cortex, amygdala, and hippocampus).  With this 
approach, a more dramatic phenotype was observed.  Using this CPEB3 cKO model, researchers 
found impaired memory formation using three distinct long-term memory paradigms. 
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Interestingly, reducing CPEB3 expression during long-memory consolidation (after the long-
term memory was established) resulted in the animals being unable to maintain a previously 
formed memory (Fioriti et al., 2015). Late phase long-term potentiation was also reduced in upon 
CPEB3 conditional knockout.  Both of these deficits could be rescued be providing exogenous 
CPEB3 via transducing viruses encoding CPEB3. The molecular circuit responsible for these 
deficits was explored, focusing on the expression of two previous identified CPEB3 targets, 
AMPA receptors subunits GluA1 and GluA2 (Huang et al., 2006; Pavlopoulos et al., 2011). The 
protein levels of both GluA1 and GluA2 were significantly increased in the hippocampus of the 
CPEB3 conditional knockout. In accord with CPEB3 regulating translation and not the 
transcription of its targets, the mRNA levels of GluA1 and GluA2 were not significantly 
different from wild-type animals.  Together these results demonstrate that CPEB3 acts as a 
translational regulator and is required for LTP and for maintenance of memory. 
 
CPEB4: 
The final member of the mammalian CPEB family, CPEB4, is also expressed in neurons 
(Theis et al., 2003).  Similar to CPEB1,CPEB4 induces polyadenylation and translation in 
Xenopus oocytes (Novoa, Gallego, Ferreira, & Mendez, 2010).  However, no overt phenotype is 
evident with complete removal of the CPEB4 gene in mice (Tsai et al., 2013).  Also, CPEB4 KO 
mice have normal synaptic plasticity and memory. These findings suggest CPEB4 is the only 
CPEB family member not required for plasticity and learning. However, the phenotype for 





CPEB is a Synaptic Mark and has Prion-Like Properties 
 
Studies in mice, Drosophila, and Aplysia demonstrate CPEB activity is induced by 
neuronal activity, is necessary for L-LTP, induces synaptic growth, and is dependent on 
translation.  These are the features of a synaptic tag required for L-LTP maintenance, leading to 
the hypothesis that members of the CPEB protein family act in this role.  To explore this 
possibility, Si and Kandel found that when a single puff of serotonin is applied to a synapse, 
apCPEB expression increases three to four-fold, but the increase is restricted to stimulated 
synapse (Si, Giustetto, et al., 2003).  This activity-dependent, local increase, which results in the 
maintenance of L-LTP, implicates that apCPEB functions as a synaptic tag.  apCPEB maintains 
L-LTP by inducing the translational proteins required for long lasting synaptic potentiation.   
Interestingly, apCPEB contains domains that are highly similar with group of prion 
proteins in yeast, known as prion-like domains.  Originally discovered by Stanley Prusiner, the 
prion protein (PrP) is unique as both the toxic agent and the infectious particle causing a group of 
mammalian neurodegenerative disorders, the transmissible spongiform encephalopathies (TSE) 
(Prusiner, 1982).  Unlike other infectious diseases in which a virus or bacterium produces toxic 
proteins or disrupts normal physiological processes, neurodegeneration in TSEs occurs when the 
normal cellular prion protein (PrPC) undergoes a structural conformation change into scrapie 
prion protein (PrPSc) (Prusiner, 1998).  While the pathogenic mechanism is still being explored, 
it is clear that the conformational shift to PrPSc imparts a highly-stable β-sheet rich structure to 
the protein that enables the formation of higher-order oligomers (Pan et al., 1993).  PrPSc 
oligomers are protease resistant variants that generate insoluble amyloid aggregates responsible 
for disease (Oesch et al., 1985; Telling et al., 1996).  Of particular relevance for this thesis, once 
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established, PrPSc  acts as a seed to convert non-pathogenic monomers of PrPC to PrPSc (Prusiner, 
1998). Using this process of continual self-renewal, PrPSc is maintained inside the cell.  
Originally considered only a pathogenic mechanism, yeast proteins were found to have prion-
like properties.  Yeast prion proteins share with PrP the capability to form distinct 
conformations.  The prion state conformation converts the non-prion state to the prion state 
(Derkatch, Chernoff, Kushnirov, Inge-Vechtomov, & Liebman, 1996).  Yeast use this 
conformational switching to rapidly alter protein function in response to environmental stress 
(Derkatch, Bradley, Zhou, Chernoff, & Liebman, 1997).  Yeast prions are passed from 
cytoplasm of the mother to the daughter cells to generate stable phenotypic changes in their 
offspring (Ganusova et al., 2006; Mathur, Taneja, Sun, & Liebman, 2010).  
Si and Kandel were intrigued why a synaptic protein responsible for regulating a long-
lasting cellular process had a prion-like domain enriched with polar glutamine and asparagine 
residues. This led to the hypothesis that apCPEB uses a prion-like conformation as a mechanism 
to establish and maintain a synaptic tag (Si, Lindquist, & Kandel, 2003). Using 
immunofluorescence and electron microscopy, it was shown that apCPEB forms oligomeric 
structures in sensory neurons.  Since thioflavin T(ThT) binds to β-sheet portions of amyloid 
proteins, a ThT binding assay can be used to determine the oligomeric composition of apCPEB 
(Si, Choi, White-Grindley, Majumdar, & Kandel, 2010).  After complete denaturing and 
refolding the protein, apCPEB strongly binds ThT but only when oligomeric structures begin to 
appear.  These and other data suggest apCPEB has amyloid-like features (Raveendra et al., 
2013).  Furthermore, apCPEB oligomers share other properties of functional prion-like proteins 
such as: 1) oligomers are assemblies of apCPEB monomers, 2) oligomers are self-sustaining by 
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recruiting additional apCPEB monomers to the assembly, and 3) apCPEB oligomers are formed 
in response to extracellular stimuli, in this instance serotonin.   
The role of apCPEB oligomers in synaptic plasticity still remained to be determined. In 
particular, can neurons still form LTP?  To answer this question, the oligomer apCPEB was 
removed by injecting an antibody that selectively recognized the oligomer.  Neurons lacking 
oligomeric apCPEB, form but cannot maintain LTP (Si et al., 2010), implying that the function 
of this higher-order structure is to sustain synaptic potentiation. 
 
Prion-Like Proteins in Memory  
 
The findings that apCPEB has prion-like properties and undergoes oligomerization with 
neuronal stimulation raises the intriguing possibility that cells utilize these self-sustaining, higher 
order assemblies to stabilize and maintain synaptic potentiation.  Depending on the context, 
CPEB-proteins can act as translational repressor or activator.  These observations provide a 
possible model in which activity-dependent stimulation converts CPEB proteins from a 
translational repressor in the monomeric state to a self-sustaining prion-like protein capable of 
maintaining LTP, thus preserving long-term memory.  Alternatively, activity-dependent 
stimulation and CPEB oligomeric conversion may act to inactivate a repressor, thereby 
permitting the translation of mRNAs required for synaptic plasticity and memory.  
Two recent studies, explore the possibility that Orb2 in Drosophila and CPEB3 in mice 
function to regulate long-term memory by amylogenic conversion. In Drosophila, Orb2 contains 
amino acid domains similar to other prion-like proteins (Keleman, Kruttner, Alenius, & Dickson, 
2007; Kruttner et al., 2012; Majumdar et al., 2012). If this domain is removed or if Orb2 
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oligomerization is inhibited by mutating a residue critical for the conversion, the transgenic flies 
are unable to form long-term memory (Keleman et al., 2007; Majumdar et al., 2012).  The 
functional role of oligomerization was further established by purifying monomeric and 
oligomeric Orb2, followed by evaluating how these two different conformational states affect 
translation in vitro (Khan et al., 2015).  Adding monomeric Orb2 represses its translational 
targets and adding oligomeric Orb2 enhances the same translational targets.  In addition, the 
effects on poly(A) elongation were examined, finding that the monomer reduces the poly(A) tail 
whereas oligomeric Orb2 elongates the poly(A) tail (Khan et al., 2015). These actions likely 
occur through conformational-dependent interactions.  Co-immunoprecipitation demonstrates 
that the Orb2 monomer directly interacts with a complex responsible for de-adenylating poly(A) 
tail and the oligomer interacts with the complex responsible for poly-adenylating.  Therefore, bi-
directional translational control by Orb2 is regulated by its conformational state.  
In the vertebrate nervous system, CPEB3 may have a similar role in synaptic plasticity as 
apCPEB in Apylsia and Orb2 in Drosophila.  CPEB3 forms aggregates after behavioral training 
and CPEB3 contains a prion-like domain in the N-terminal of the protein (Fioriti et al., 2015). 
When the N-terminal prion-like domain is removed and transfected into cells, CPEB3 fails to 
form oligomers (Fioriti et al., 2015).  To determine if CPEB3 oligomerization is critical for the 
formation of long-term memory, wild-type or N-terminal lacking CPEB3 expressing viruses 
were introduced into hippocampal neurons of CPEB3 knockout mice (which cannot form long-
term memory).  The transduced WT CPEB3 rescues the memory phenotype, but N-terminal 
lacking CPEB3 does not. Likewise, transducing N-terminal lacking CPEB3, does not rescue the 
LTP deficit observed in CPEB3 null mice.  These results suggest that the oligomerization of 
CPEB3 is critical for long-term potentiation and the maintenance of long-term memory. 
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Our understanding of functional prion-like proteins in normal physiology is in its infancy.  
Only a small number of prion-like proteins have been explored in all taxa and few of those 
studies have focused on mammals.  The goal of my thesis is to determine if other mammalian 
CPEB family members function similar to apCPEB, CPEB3, and Orb2 in regulating synaptic 
plasticity and the formation of long-term memory.  In addressing this question, this thesis seeks 
to determine if prion-like proteins are more abundant and critical than previously thought. To 
this end, the thesis first examines if other members of the CPEB family (CPEB1, 2, and 4) share 
prion-like domains with other known prion proteins.  We identified the most “prion-like” of the 
CPEB family member based on sequence homology.  This led to the hypothesis that CPEB2 
plays a central role in synaptic plasticity and long-term memory.  
To test this hypothesis, the thesis first examines if CPEB2 forms higher-order structures 
as observed for apCPEB, CPEB3, and Orb2.  Once we determined CPEB2 assembles into 
oligomeric species, we sought to selectively inhibit CPEB2 oligomers from developing. The 
strategy involved generating a mouse model that expresses a truncated form of CPEB2 without 
its prion domain by modifying the endogenous mouse locus. Using this mouse model, I assayed 




Chapter 2: CPEB2 is a putative prion-like protein and forms higher-order 
oligomers in neurons 
 
CPEB2 is rich with “low-complexity” and “prion-like” sequences 
 
The finding that prion-like domains allow proteins to adopt different physical states and 
function prompted us to interrogate how prevalent such proteins are in the nervous system and 
whether they influence normal function of the nervous system. Prion-like domain often have 
specific characteristic that includes amino acid composition, structural features. To identify 
prion-like motifs we employed two bioinformatic tools to compare the whole mammalian 
proteome as well as sequences of individual members of the mammalian CPEB family.  The first 
tool, the SEQ algorithm, scores the amount of low-complexity based on the primary protein 
sequence (Wootton & Federhen, 1996).  Sequences with high “low-complexity” scores contain a 
large number of repeats consisting of either motifs or single amino acids.  Prion-like domains are 
a subset of these “low-complexity” domains (Harrison & Shorter, 2017).  The second tool we 
used was Prion-Like Amino Acid Composition analysis (PLAAC), which scores protein 
sequences based upon the degree of homology with known prion-like proteins (Lancaster, 
Nutter-Upham, Lindquist, & King, 2014).  
 We used the sequences of the predominant isoforms of the mouse CPEB family members 
to perform the analysis.  CPEB2 had the highest degree of low-complexity sequence (0.32) (Fig 
2.1A).  In comparison, CPEB3 had a low-complexity score of 0.17.  CPEB3’s score was similar 
to CPEB4 at 0.145.  CPEB1 had the lowest score at 0.06. When we scored the CPEB proteins for 
prion-like sequences using PLAAC, CPEB2 had the highest prion-like score (20.0).  CPEB3 
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scored a close second (19.4) (Fig 2.1B).  CPEB4 had a mid-range score (9.5).  CPEB1 had a 
negative score.  These results agree with previous findings that CPEB2-4 are in a super-group 
and are distinct from CPEB1 (Huang et al., 2006).  Our analysis suggests CPEB2 contains prion-
like sequences.  This has also been demonstrated for CPEB3 (Drisaldi et al., 2015; Fioriti et al., 
2015; Stephan et al., 2015).  Prion-like domains are rich in glutamine (Q) and asparagine 
residues (N).  To further investigate CPEB sequences for features consistent with prion-like 
regions, we next examined the number of Q and N residues in the different proteins. The total 
amino acid composition of CPEB2 and CPEB4 is similarly rich in Q and N residues relative to 
CPEB3 (9.7%, 10.8%, and 11.4% respectively) (Fig 2.1C).   
CPEB1 has a lower percentage of Q and N residues (6.2%). Finally, we used the same 
analyses to compare the low-complexity scores and prion-like domains for members of the 
mouse CPEB family relative to all sequences in the mouse proteome.  We calculated the low-
complexity score and prion-like scores for all sequences in the proteome.  CPEB2-4 clustered to 
the right with a remarkably high low-complexity compared to the entire proteome, yet the 
complexity of CPEB1 is similar to the entire proteome (Fig 2.1D).  When the prion-like 
sequences in the CPEB family are compared to the entire mouse proteome, CPEB2-4 exhibit a 
higher prion-like like score than 95% of the proteome (Fig 2.1E), with CPEB-2 having the 
highest score.  This prompted us to further explore CPEB-2.  Even though a similar argument 
could be made for CPEB4, we did not consider it further in light of previous studies reporting 
CPEB4 deletion had no effect on synaptic plasticity or long-term memory. Therefore, of the 
remaining members of the CPEB family in the mouse, we thought CPEB2 was the strongest 










Figure 2.1 Characterization of the Low-Complexity and Prion-Sequences of CPEB family.  
Amino acid sequence of full-length CPEB isoforms was evaluated by bioinformatics for low-
complexity and prion-like sequences.  (A). CPEB2 isoforms are least complex. SEQ analysis of 
degree of low-complexity sequence in individual CPEB isoforms.  A higher low-complexity 
score indicates less varied sequence.  (B). CPEB2 isoforms are most prion-like. CPEB1-4 
sequence prion-like score by PLAAC analysis. Higher Prion-like score in indicates greater 
sequence homology with known yeast prion-like proteins. (C). Percent of glutamine (Q) and 
asparagine (N) residues to total amino acids of CPEB1-4. (D). Mouse proteome SEQ analysis of 
low-complexity sequence. Each dot represents gene from proteome, CPEB1-4 families 
highlighted in color. Sequences were sorted by lowest to highest low-complexity.   (E). Mouse 
proteome PLAAC analysis of Prion-like score. Each dot represents gene from proteome, CPEB1-
4 families highlighted in color. Sequences were sorted by lowest to highest prion-like score.  
Mouse reference proteome: UP000000589. 
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CPEB2 forms higher-order structures in cultured cells and neurons 
 
Having established that the amino acid sequence of CPEB2 has similar sequence 
properties to the amylogenic CPEB3, the next step was to test whether CPEB2 shares features of 
prion-like proteins, in particular, the ability to, form stable oligomeric or disorganized 
aggregated structures.  As a first step to assess whether CPEB2 aggregates in cells, a N-terminal 
GFP-tagged CPEB2 driven by the mammalian promoter CMV was transfected into HEK293T 
cells.  We used fluorescence microscopy to visualize GFP-CPEB2 transfected cells.  We found 
CPEB2 formed aggregated puncta of differing sizes which were broadly distributed throughout 
the cytoplasm of HEK293T cells (Fig 2.2A).  We also analyzed lysates from CPEB2-GFP 
transfected cells by SDS-page western blot to assay the nature of the CPEB2 aggregates.  CPEB2 
was visualized by immunoblotting with an antibody against GFP.  We found CPEB2 was present 
at the expected molecular weight of 150kD (CPEB2 110kD including GFP 27kD).  
Unexpectedly, a band of a much larger molecular weight (>200kD) with an underlying “smear” 
was also visualized on the blot.  It should be emphasized that we prepared the protein lysates 
under denaturing conditions suggesting CPEB2 likely forms highly stable oligomers.  
After observing CPEB2 aggregation in an immortalized mammalian cell line, we next 
investigated CPEB2 localization and whether it forms aggregates in primary neuron cultures.  
The first step was to isolate and culture hippocampal neurons from post-natal day 18 (p18).  In-
vitro, hippocampal neurons are phenotypically similar to pyramidal neurons and develop axons, 
dendrites, and spines that form synaptic connections (Kaech & Banker, 2006).  Once the cultures 
reached maturity, we transfected them with the same GFP-tagged CPEB2 construct in the 
previous experiments.  We used MAP2K immunostaining to differentiate transfected neurons 
	
	 27	
from transfected glia.  Similar to the expression in HEK293T cells, fluorescence microscopy 
revealed large positive CPEB2 punctae throughout the neurons (Fig 2.2C, D).  Of interest, small 
CPEB2 punctae were also present in neurites (Fig 2.2D – red arrows). These results illustrate that 
when overexpressed, CPEB2 aggregates in cultured neurons and the aggregates are located in the 
dendrites, and likely near the synaptic sites. 
Figure 2.2 
 
Figure 2.2 Subcellular localization and aggregation properties of transfected CPEB2-GFP 
in HEK293T cells and cultured hippocampal neurons.  Transfected CPEB2-GFP forms 
aggregated puncta and higher-ordered oligomers in HEK293T cells.  In cultured hippocampal 
neurons, transfected CPEB2-GFP positive puncta are present in cytoplasm and neurites.  (A)  
Fluorescence from expressed CPEB2-GFP in HEK293T cells. (B) Western blot of non-
transfected and CPEB2-GFP transfected HEK293T cell lysates, probed with anti-GFP antibody. 
Notice there is a large oligomeric smear of CPEB2. (C) and (D) Fluorescence expression of 
CPEB2-GFP in hippocampal neurons (green).  The cultures were counter-stained with MAP2K 
to label hippocampal neurons (red). Number of neurons (n) assessed for each genotype: wild-




Generation of CPEB2 isoform specific knock out  
 
 The sequence analysis and cell-based studies outlined above suggested that CPEB2 has 
the ability to form stable aggregates when ectopically expressed.  Therefore, we sought to 
determine whether endogenous CPEB2 displays oligomeric properties and whether those 
properties are critical for synaptic plasticity and long-term memory.  To test this end we 
generated a mouse model in which the ability of CPEB2 to oligomerize was disrupted.  
For the first phase of this experiment, we used PLAAC analysis to identify the sequence 
location of CPEB2 prion-like domain.  In mice, the Cpeb2 gene has 12 exons and encode three 
distinguishable protein encoding-transcripts varying between 110 and 30 kD (CPEB2-201,-202,-
204) (Fig 2.4A).  We identified a probable prion-like domain in the C-terminal portion of the 
exon 1 of CPEB-201 and CPEB-204 (Fig 2.3B).  After identifying the sequence harboring the 
prion-like domain, we devised a knockout strategy to generate the Cpeb2 gene with exon 1 
deleted.  We targeted two guide RNAs against the 5’ and 3’ intronic regions of exon 1.  They 
were delivered with CRISPR-CAS9 into the mouse embryo (Fig 2.3C).  The aim was to induce 
double stranded breaks at both guide RNA loci, followed by non-homologous end joining of the 
cut chromosome in order to remove the exon 1 of Cpeb2 and with it the prion-like domain (Fig 
2.3C).  Even though this approach removes the first start codon, another in-frame methionine is 
still present at the 5’ end of exon 2.  We anticipated that the in-frame methionine of exon 2 could 
generate a truncated CPEB2 protein lacking the prion-like domain (Fig 2.3C).  
 The pups produced after pronuclear injection and embryo implantation were screened by 
PCR and sequencing for transgenic founders in which exon 1 was removed.  We identified a line 
that completely lacked exon 1 and the prion-like domain (CPEB2 PD).  We used a heterozygous 
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CPEB2 PD mating strategy to obtained wild-type, heterozygous, and homozygous mice at the 
expected Mendelian ratios (Fig 2.3D).  The homozygous CPEB2 PD mice did not exhibit 
obvious physical defects and remained in excellent health for at least a year (data not shown).  
The normal viability and expected Mendelian ratios of the offspring of the CPEB2 PD model 
suggest, in contrast to the full knockout, that a vital form of CPEB2 was being produced.  To this 
end, to determine if additional truncated transcripts were present, we isolated mRNA transcripts 
from the brain and analyzed the various forms of CPEB2 mRNA expression by reverse 
transcription-coupled PCR (RT-PCR). For this assay, we used forward primers from CPEB2 
exons 1, 2, and 3 with reverse primers to regions of the C-terminal exons.  CPEB2 PD mice 
specifically lack transcripts containing the exon 1 (Fig 2.3E).  However, these mice contain 
transcripts of exon 2 and exon 3 that are similar in size to the wild-type mice CPEB2-202 
transcripts (Fig 2.3E).  Given that CPEB2 PD animals lack exon 1 and its annotated start codon 









Figure 2.3 Generation of CPEB2 PD-/- mouse model. (A) Schematic of Cpeb2-201, Cpeb2-
202, Cpeb2-204 isoforms.  Cpeb2-204 and Cpeb2-201 contain first exon. (B) CPEB2 has 
predicted prion-like domain in exon 1.  Top: Output format of PLAAC prion-like prediction 
algorithm for Cpeb2-204. Orange trace is predicted probability of individual amino acid 
belonging to prion-like domain region (PRD). Black trace is probability the sequence is not 
prion-like. Bottom: schematic of Cpeb2-204 protein aligned to prion-like prediction.  Shown in 
color are CPEB2 protein domains: prion-like domain in orange, RNA recognition motifs 1 and 2 
in blue (RRM), and zinc finger domain in green (ZnF).  (C) Top: strategy for the generation of 
the CPEB2 PD-/- mice. Guide RNAs were targeted intronic regions flanking exon 1 of Cpeb2. 
Guide RNAs and CAS9 protein were introduced into the pronucleus by microinjection to 
selectively excise exon 1 of Cpeb2. Bottom: predicted truncated CPEB2 protein lacking exon 1 
and prion-like domain. (D) Normal distribution ratios of WT, heterozygous, and homozygous 
CPEB2 PD-/- mice produced from heterozygous CPEB2 PD+/- mating. Numbers in parenthesis 
denote the number of mice in each genotype. (E) Reverse transcription coupled PCR analysis 
(RT-PCR) demonstrated loss of transcripts containing exon 1 in CPEB2 PD-/- mice. RNA 
isolated from brains was reverse-transcribed and PCR-amplified for Cpeb2 using forward 
primers designed in exons 1, 2, and 3 and reverse primers designed against multiple C-terminal 
exons junctions. No difference was observed in the transcripts containing exon 2 or 3 between 




The next experiments investigated the level of the full-length CPEB2 (CPEB2-204) 
protein (which contains exon 1) in CPEB2 PD animals.  We processed lysates from wild-type, 
heterozygous CPEB2 PD+/-, and homozygous CPEB2 PD-/-mouse brains for western blots.  We 
used a CPEB2 specific antibody that recognizes the C-terminal portion of CPEB2 common to all 
CPEB2 protein variants.  In brain lysates prepared from wild-type mice at p5 and 405p, the 
affinity-purified CPEB2 antibody detects an 115kD weight protein that corresponds to full length 
CPEB2-204 (Fig 2.4A).  In lysates prepared from CPEB2 PD-/- mice no proteins were detected at 
115kD (Fig 2.4A).  The 115kD is observed in CPEB2 PD+/- mice at lower levels (Fig 2.4A).  
These results illustrate that full length CPEB2 isoform is not expressed in CPEB2 PD-/-.  
Additionally, 35kD band is detected (Fig 2.4A) in CPEB2 PD-/- samples and is also detected in 
wild type controls.  This band likely represents the smallest isoform of CPEB2 (31 kD), CPEB2-
202 that lacks the majority of exon 1. 
We isolated hippocampal neurons from wild-type and CPEB2 PD-/- mice to better 
understand the expression and distribution of endogenous CPEB2 protein in vivo.  We stained 
them with CPEB2 specific antibody for detection by immunofluorescence and observed diffuse 
endogenous CPEB2 throughout the neurons. When compared to wild type, immunodetection of 
endogenous CPEB2 in CPEB2 PD-/- was clearly diminished.   Considering that the antibody used 
is against C-terminus of CPEB2, the residual immunofluorescence detected here may represent 
truncated CPEB2-protein.  Taken together, these data suggest the CPEB2 PD mouse model lacks 






Figure 2.4 Characterization of CPEB2 expression in CPEB2 PD-/- mouse model.  CPEB2 
PD-/- mice lack expression of full-length CPEB2.  (A) Western blot analysis of CPEB2 
expression in brains from wild-type, CPEB2 PD+/-, and CPEB2 PD-/- mice at p5 and 405 days of 
age.  CPEB2 was detected with affinity-purified CPEB2 antibody. Full-length CPEB2 is absent 
in CPEB2 PD-/- mice and a smaller protein correlating to the truncated CPEB2 protein is at 35kD 
at p5. A protein corresponding to smallest CPEB2 isoform (31kD), Cpeb2-202, is observed in 
wild-type mice at p5.  (B) CPEB2 immunofluorescent expression is diminished in CPEB2 PD-/- 
neurons. Immunofluorescent confocal images taken at 60x of wild-type and CPEB2 PD-/- 
cultured hippocampal neurons immunostained with CPEB2 antibody.  
 
CPEB2 forms higher-order structures in vivo   
 
Supplied with both a prion-domain lacking CPEB2 mouse model and an antibody 
specific to CPEB2 we were able to reliably asses the formation of CPEB2 oligomers in vivo.  We 
fractioned by size, brain lysates from wild-type and CPEB2 PD-/- to perform this analysis.  We 
followed a protocol that uses a series of centrifugations to isolate increasingly heavier 
components of the cell (Fig 2.5A).  CPEB2 is an RNA binding protein and potentially found in 
large stable RNA-protein complexes.  To control for this, brain lysates were pretreated with the 
nuclease, benzonase.  Benzonases degrade all forms of DNA and RNA and, as a result, 
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dissociate proteins from RNA-protein complexes.  At the end of the centrifugation steps, 
immunodetection determined the amount of CPEB2 in each fraction using the CPEB2 specific 
antibody.  In wild-type mice, full length and oligomeric CPEB2 were present in each fraction 
(Fig 2.5B).  In the CPEB2 PD-/- lysates, neither full length nor oligomeric CPEB2 expression 
was observed (Fig 2.5B).  However, because SDS-PAGE has several confounding factors when 
used to analyze high-order structures, including pore-size limitation, we also employed SDD-
agarose (SDD-AGE) gel analysis.  SDD-AGE gels have significantly larger pore size and enable 
visualization of large SDS-resistant oligomers.  SDD-AGE gels are routinely used to resolve 
mammalian amyloidogenic aggregates (Bagriantsev, Kushnirov, & Liebman, 2006).  In the semi-
denaturing conditions of SDD-AGE, prions and prion-like proteins oligomers are maintained, 
while disordered aggregates disassemble (Kryndushkin, Alexandrov, Ter-Avanesyan, & 
Kushnirov, 2003).  
Wild type fractions run in SDD-AGE showed both a monomeric CPEB2 band and large 
molecular weight-smears, suggesting CPEB2 formed amyloid-like oligomers (Fig 2.5C).  There 
was no evidence of CPEB2 monomers or oligomers in the fractions from the CPEB2 PD-/-.  To 
further assess the nature of the oligomers, medium weight S2 fractions from both wild-type and 
CPEB2 PD-/- were treated with increasing concentrations of the reducing agent dithiothreitol 










Figure 2.5 CPEB2 forms oligomeric structures in vivo. (A) Schematic diagram of the brain 
lysate fractionation procedure using several differential centrifugation steps.  Six distinct 
fractions of increasing heavier components were isolated. Fractions assayed by western blots and 
SDD-AGE are shown in red (Blots: B-D).  (B) Western blots of the different cellular fractions 
show monomeric and oligomeric CPEB2 in each fraction from wild-type mice.  Neither 
monomeric nor oligomeric CPEB2 is present in CPEB2 PD-/- mice.  (C) SDD-AGE analysis for 
CPEB2 oligomers in cellular fractions from wild-type and CPEB2 PD-/- mice.  Smear of SDS-
resistant oligomeric CPEB2 is observed in wild-type mice but not CPEB2 PD-/- fractions.  (D) 
SDD-AGE analysis determining CPEB2 oligomer stability in S2 fractions treated with increasing 
concentration of DTT.  CPEB2 oligomers were resistant to reduction by DTT. (E) Schematic of 
procedure for isolating brain lysates from animals at p5, 3 months, 9 months, and 14 months. S2 
fraction was assayed by western blot and SDS-AGE (Blots: F-G) (F) Western blots of S2 lysates. 
CPEB2 protein is expressed at each time point in wild-type mice. (G) SDD-AGE analysis of 
CPEB2 oligomers at each age.  SDS-resistant oligomer CPEB2 is present in lysates of wild-type 
mice at 3, 9, and 14 months of age.  CPEB3 oligomers are found in wild-type and CPEB2 PD-/- 




Since DTT reduces proteins and prevents intramolecular and intermolecular disulfide 
bonds, these results suggest CPEB2 linkages are either not readily reducible or not necessary for 
maintenance of SDS-resistant CPEB2 oligomers. To determine whether CPEB2 oligomers are 
transiently present at a particular stage or present throughout the mouse’s lifespan, western blot 
analysis was used to first confirm CPEB2 expression in brain lysates prepared from a variety of 
times points (Fig 2.5E).  We found CPEB2 present throughout the different aged animals (Fig 
2.5F).  Next, we assayed the CPEB2 oligomers in these lysates using SDD-AGE (Fig 2.5G).  The 
CPEB2 oligomers are detected in 4, 9, and 14 months old in wild-type mice (Fig 2.5G).  Again, 
no oligomers were detected in CPEB2 PD-/- mice (Fig 2.5G).  As an additional control, we 
assessed if either the known prion-like protein, CPEB3, or a non-prion synaptic protein, 
synaptotagmin, form oligomeric smears in this assay.  As previously observed, CPEB3 forms 
oligomers (Fioriti et al., 2015; Turimella et al., 2015), but synaptotagmin does not (Fig 2.5 
Appendix 3: Regulation of Amyloidogenic Oligomerization of Drosophila Orb2 Protein G).  In 
summary, these results demonstrate that CPEB2 forms SDS-resistant oligomers in the brain 






This chapter provides data that suggest CPEB2 may be a prion-like a protein.  
 
CPEB2-4 super family is rich in prion-like sequences: 
 
To identify whether additional members of the CPEB family harbor prion-like domain, 
the amino acid sequences of CPEB proteins were assayed for low-complexity regions and prion-
like sequences found in prion-like proteins.  The analysis revealed that CPEB2-4 have regions 
containing little amino acid diversity and share sequence homology with other prion-like 
proteins.  Of the family members, CPEB2 has the highest low-complexity scores and highest 
degree of homology with other known prion-like proteins.  This suggests CPEB2 is a potential 
prion-like protein.  The algorithm to screen for prion-like sequence is based on the amino acids 
found in 28 yeast proteins that have distinct conformational shapes or that form amyloid 
structures (Lancaster et al., 2014).  Importantly, this technique is used to identify prion-like 
sequences in mammalian proteins (H. J. Kim et al., 2013; King, Gitler, & Shorter, 2012).  
Therefore, the sequences of CPEB2-4 are highly rich in amino acids found in proteins with 
prion-like features.  In particular, CPEB2 strongly meets these criteria. 
To determine if these features are unique to the CPEB family, we analyzed the degree of 
low-complexity and prion-like sequences in the entire genome and show CPEB2-4 are rich with 
low-complexity sequences relative to the genome.  Low-complexity regions are relatively 
abundant in the genome (Golding, 1999).  Their functions are still relatively unknown.  Prion-
like domains are low complexity sequences comprised of polar amino acids (glutamine, 
asparagine, typrsine, and serine) (Alberti, Halfmann, King, Kapila, & Lindquist, 2009; L. Li & 
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Lindquist, 2000; Michelitsch & Weissman, 2000).  Previous studies demonstrate that CPEB3 
contains a prion-like domain that promotes amyloid aggregation (Drisaldi et al., 2015; Fioriti et 
al., 2015; Stephan et al., 2015).  Additionally, when expressed in the nervous system, the N-
terminal low-complexity region of CPEB4 forms nucleolar aggregates (Shin, Salameh, & 
Richter, 2016).  Given these conclusions, we hypothesized that the low-complexity of CPEB2-4 
is associated with the presence of their prion-like sequences.  Supporting this hypothesis, 
CPEB2-4 prion-like prediction scores are higher than 95% of the genome.  In addition, the low-
complexity regions of CPEB2-4 are predominantly in exon 1, which is in agreement with our 
own and others’ PLAAC analysis.  (Appendix 1) (Fioriti et al., 2015; Shin et al., 2016).  The 
CPEB2-4 exon 1 share relatively low-homology, but the prion-like sequence of CPEB2-4 is 
found in exon 1 (Appendix 1).  Interestingly, a disproportionate number of human RNA-binding 
proteins, such as CPEB, contain prion-like domains (Harrison & Shorter, 2017).  Clues to the 
role of prion-like domain in RNA-binding proteins come from studies demonstrating that upon 
cellular or environmental stress a number of RNA-binding proteins with prion-like domains are 
recruited into stress granules (Anderson & Kedersha, 2008; Y. R. Li, King, Shorter, & Gitler, 
2013).  Stress granules are cytoplasmic structures consisting of the translational machinery and 
mRNAs that serve to repress translation of unnecessary proteins, in order to devote more cellular 
resources toward production of more critical proteins required for survival (Harrison & Shorter, 
2017).  Thus, these domains are essential for protein-protein interactions to function correctly in 
response to environmental stimuli.  Likewise, in apCPEB and CPEB3, these domains also 
promote aggregation upon neuronal stimulation (Fioriti et al., 2015; Si et al., 2010).  However, 
neither oligomeric CPEB3 nor apCPEB localize stress granules.  Instead of repressing 
translation, CPEB is associated with active translation.  Therefore, considering that these 
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domains have been preserved in both CPEB2 and CPEB4, the prion-like sequence similarities 
between CPEB2-4 superfamily raises the possibility that CPEB2 and CPEB4 require their prion-
like domain in order to function.  
 
CPEB2 PD-/- is an isoform specific knockout 
 
We focused on CPEB2 due to its prion-like amino acid sequence properties and its role in 
synaptic plasticity and long-term memory (Lu et al., 2017).  We generated a CPEB2 knockout 
mouse lacking the prion-like domain to further characterize the prion-like properties of CPEB2.  
After identifying that a putative prion-domain resides in the exon 1 of CPEB2, a CPEB2 prion-
domain knockout was generated by removing exon 1 from the endogenous mouse locus using 
CRISPR-CAS9.  Initial characterization of the CPEB2 PD-/- model showed successful removal 
of exon 1 from the mouse genome.  Importantly, in CPEB2 PD -/- mice, CPEB2 transcripts 
containing the exon 1 were absent but, transcripts containing the exon 2 and exon 3 were present.  
Additionally, CPEB2 PD -/- mice did not express the full-length CPEB2 protein.  We generated 
and used an antibody targeted against the C-terminal portion to assay the CPEB2 protein.  
Considering that CPEB2 PD -/- mice still contain this region and transcribe CPEB2 transcripts 
containing exon 2, we reasoned that our knockout is isoform specific and would express a 
truncated version of the CPEB2 protein.  The data support this hypothesis.  In wild-type animals 
we observed a protein corresponding to the smallest CPEB2 isoform (CPEB2-202), which 
correlates to the predicted truncated CPEB2 protein observed in the knockout.  These two 
proteins are of comparable size, given that the smallest isoform contains only 16 amino acids of 
the first exon.  These findings indicate that the CPEB2 PD-/- model is a CPEB2 isoform specific 
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knockout.  Other functional and structural domains identified in CPEB2 (two RNA recognition 
motifs and a zinc finger) reside in the distal C-terminal portion (Fig 2.3B, C) (Turimella et al., 
2015).  As described above, the complete CPEB2 knockout mouse model in which exons 3-5 are 
deleted is lethal in the prenatal and early postnatal period.  In that case no protein or truncated 
protein is produced (Lai et al., 2016).  We hypothesized that a truncated CPEB2 protein 
containing the functional and structural domains may maintain the essential CPEB2 functions 
required to generate a viable animal.  We observed that CPEB2 PD-/- animals are viable and only 
express a CPEB2 truncated protein.  Taken together these results indicate that the truncated 
CPEB2 PD-/- model maintains a CPEB2 truncated form with functional domains in the C-
terminus that is sufficient for CPEB2 functions in early development.   
 
CPEB2 as a putative prion-like protein 
 
  The next experiments addressed whether CPEB2 shares features with other prion-like 
proteins.  First, we established that CPEB2 forms large aggregates in tissue culture cells and 
hippocampal primary cell cultures.  When overexpressed, large CPEB2 aggregates form in tissue 
culture cell and primary hippocampal neurons.  Next, we used CPEB2 PD -/- mice to test if 
CPEB2 forms oligomeric structures in vivo.  The results showed high molecular weight 
oligomers are present in wild-type mice but not in CPEB2 PD -/- mice.  Likewise, when wild-type 
brain lysates were examined by SDD-AGE, a smear of SDS-resistant high molecular weight 
CPEB2 was detected.  Our CPEB2 isoform specific knockout did not form these structures.  In 
addition to being SDS-resistant, the CPEB2 oligomer was resistant to reducing conditions with 
increasing concentrations of DTT and was present throughout the lifespan of the mouse.  The 
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presence of high molecular weight CPEB2 oligomers is intriguing for two reasons.  First, this 
finding demonstrates CPEB2 forms large oligomers in-vivo.  Second, it establishes that similar to 
CPEB3, CPEB2 is another mammalian CPEB family member capable of forming SDS-resistant 
oligomers.  The full-length CPEB2 shares features with prion-like proteins including, 1) forming 
high molecular weight structures, and 2) the oligomers being resistant to reducing detergents. 
However, it remains to be determined whether CPEB2 meets the other two criteria important for 
establishing its identity as a functional prion, 1) formation of fibers, and 2) ability to convert 
monomeric CPEB2 to the aggregate form.    Regardless of the classification, we demonstrated 
that the formation of the oligomeric CPEB2 is imparted by exon 1 containing the prion-like 
domain.  Consistent with the results shown here, removing the N-terminal portion of CPEB3, 
which contains it prion-like domain, reduces the formation of the prion-like oligomeric CPEB3 
(Stephan et al., 2015).  Likewise, the LTP and long-term memory deficit observed in the CPEB3 
cKO mice can be rescued by transducing full-length CPEB3. But, they cannot be rescued by 
CPEB3 lacking the N terminus.  In the remaining chapters, we explore the effect of removing the 
CPEB2’s exon 1 and its prion-like domain on CPEB2-dependent translation, synaptic plasticity 




Chapter 3: CPEB2’s role in translation  
 
CPEB2 associates with translating ribosomes 
 
The formation of long term-memory requires stimulus-dependent synthesis of new 
proteins by neurons, from existing but dormant mRNA or from newly transcribed mRNAs. In 
mouse forebrain, CPEB2 effects the formation of long-term memory, likely by acting as a 
translational regulator of key mRNAs. Selective loss of CPEB2 in the forebrain affects the 
formation of long-term memory and the regulation of the translation of target genes in (Lai et al., 
2016; Lu et al., 2017; Turimella et al., 2015). Further, CPEB2 in the nervous system acts both as 
a translational repressor and as an activator (Lai et al., 2016; Lu et al., 2017).  Previous studies 
analyzed CPEB2 translational effects on a small subset of genes, which limits generalization. We 
sought to gain a more unbiased and fundamental understanding of CPEB2-dependent translation 
regulation by first exploring which phase of translation CPEB2 is present. 
To better understand the role of CPEB2 in translation, we used polysome profiling which 
separates ribosomes according to their translational status. Polysome profiling also allows us to 
discriminate ribosomes that are actively elongating mRNA (Chasse, Boulben, Costache, 
Cormier, & Morales, 2017) from ribosomes that are not engaged in translation and therefore can 
serve as an indicator of overall translation status of the cell.  Additionally, following the 
separation of ribosomes, the proteins and mRNAs associated with the different types of 
ribosomes can be indentified. For example, translating ribosomes associate with the translational 
machinery, translational activators, and other translational regulators (Chasse et al., 2017). 
Typically, translation repressors are found with dissociated ribosomes and untranslated mRNAs. 
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Polysome profiling enabled us to determine if CPEB2 associated with ribosomes. Further, using 
this technique, we could identify if CPEB2 associates with either untranslating or translating 
ribosomes, 
Polysome profiling begins with arresting translation and immobilizing the ribosome onto 
the mRNA by treating brain lysates with the protein synthesis inhibitor, cycloheximide.  
Translationally active ribosomes form groups of multiple 80S ribosomes or chains of ribosomes 
(polysomes), and are separated from ribosomal subunits not undergoing translation by a sucrose 
gradient.  Following centrifugation, the gradient is fractionated and the amount of RNA in each 
fraction quantified using an absorbance wavelength of 260 nm (A260).  The mRNA transcripts 
being highly translated are bound by two or more 80S ribosomes and reside in the heaviest 
sucrose fractions (polysome fractions) (Fig 3-1A).  Conversely, single ribosomal subunits and 
free mRNAs are present in the lighter fractions (Fig 3-1A).  Following sucrose gradient 
separation, proteins present in the translating or non-translating fractions can then be assayed by 
western blot.  Using this technique, we asked which fractions contained CPEB2 to determine the 








Figure 3.1 CPEB2 associates with polyribosomes. Polysome profiling conducted on lysates 
prepared from brain cortices of 3 month old wild-type mice. (A) and (C) Cartoon showing 
sedimentations patterns of the mRNAs during different translational phases in each type of 
sucrose gradient. (B) and (D) Top panel: RNA absorption profile of 7-47% (w/w) sucrose 
gradient at 260 nm absorbance. 80s ribosomal and polysome peaks are indicated.  Bottom panel: 
western blots show distribution of CPEB2, CPEB3, Fragile X, 40S ribosomal subunit S6(RS6) 
and tubulin in relation to absorption profile.  Fraction numbers are indicated underneath; faction 
1 is lightest and 14 is heaviest.  In (B) polysome profiling on untreated lysates shows CPEB2 co-
sediments with the polyribosomes in fractions 8-14. In (D) EDTA treated lysates RNA 
absorption profile shows loss of polyribosome peaks due to dissociation of ribosomes. In absence 




Whole brain lysates from 3 month old wild-type mice were analyzed by polysome 
profiling.  The lysates were fractionated as described above.  A typical RNA profile from these 
experiments includes a large 80S ribosomal complex represented by a high level of A260 
absorbance peak in fractions 5 and 6 (Fig. 3-1B).  The multiple small peaks in fractions 8-14 
correspond to the polysomes, with each successive peak corresponding to an additional ribosome 
per transcript (Fig. 3-1B).  Following quality-control profiling, the samples were run on western 
blot to assay levels of individual proteins found in each fraction. The blots were probed for the 
40S ribosomal subunit S6 (rS6) to determine the distribution of 40S, 60S, and 80S ribosomal 
subunits. 
As shown by the western blots, the light fractions (1-4), which is primarily composed of 
free mRNA or small RNP-complexes contains low amounts of ribosomes, including 40S 
ribosomes (Fig. 3-1B: lower panel).  The fractions corresponding to the ribosomal 80s 
complexes and polysomes have increased levels of rS6 since they contain both 40s and 60S 
ribosomes (Fig. 3-1B: lower panel, fractions 6-14).  Interestingly, CPEB2 was found in the 
polysome fractions associated with elongating mRNAs (fractions 8-14).  CPEB3 which activates 
translation, and Fragile X mental retardation protein (FMRP), which associates with elongating 
mRNAs, were used as controls and were also found in these fractions (Fig. 3-1B: lower panel).    
These results suggest CPEB2 is in a complex with mRNA actively undergoing translation. 
To confirm whether CPEB2 associates with mRNAs undergoing translation, we first 
dissociated 80S ribosomes in the solution and then measured CPEB2 distribution.  To sequester 
the Mg2+ required for ribosomal stability, the lysates were treated with 30 mM EDTA, and we 
used a sucrose gradient containing 10 mM EDTA.  This results in dissociation of the translating 
80S ribosomal subunits to 40S and 60S subunits and release of the translating mRNA and 
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translational regulators (Fig 3-1C).  As shown in the figure, after EDTA treatment there are no 
80S ribosome or polysome peaks seen by A260 (Fig 3-1D) and all the mRNAs sediment in the 
earlier fractions because they weigh significantly less without the ribosomes.  As a consequence 
of dissociating the ribosomes, proteins bound to the polysomes or their mRNA also shift to the 
earlier fractions.  Dissociation of ribosome subunits in the lysate is a key control to differentiate 
the heavy fraction proteins that complex with mRNA undergoing translation from those that do 
not.     
We subjected wild-type brain lysates to this protocol and found, as predicted, ribosome 
levels increase in the earlier, lower weight fractions and decrease in the later, higher weight 
fractions, as indicated by absorbance of the ribosomal RNA at A260 (Fig 3-1B, top).  The shift of 
ribosomal protein S6 toward the earlier fractions illustrates how this ribosome dissociation 
condition shifts their distribution from high weight to lower weight fractions (Fig 3-1B: lower 
panel, fractions 1-7).  In this case, the polysome mRNA binding protein, FRMP, also shows a 
similar shift toward the earlier fractions.  Tubulin, which does not bind mRNAs or the ribosomal 
complex, does not shift.  Following EDTA treatment, CPEB2 levels demonstrate a loss of 
CPEB2 protein in the polysome fractions and an increase in earlier fractions.  These results 
suggest that CPEB2 binds to mRNA transcripts that are being actively translated and imply 
CPEB2’s functions to regulate mRNAs undergoing translation. 
 
CPEB2 acts as a translational repressor 
 
The previous results established CPEB2 interacts with mRNAs undergoing translation. 
One possibility is that CPEB2 bound to polysomes acts as a translational activator, like Orb2, by 
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promoting polyadenylation (Khan et al., 2015).  However, two studies to date have provided 
evidence on CPEB2 acting as both a translational repressor (of choline acetyltransferase in the 
peripheral nervous system) and a translational activator (of GRASP1 in the hippocampus) (Lai et 
al., 2016; Lu et al., 2017).  To reconcile these seemingly conflicting observations, one hypothesis 
is that different CPEB2 isoforms or CPEB2 oligomers have different regulatory effects on 
translation.  To address this hypothesis, we investigated whether the translational targets of 
CPEB2 are up- or down- regulated in the isoform specific CPEB PD-/- mouse model. 
In neurons, CPEB2 binds to mRNAs encoding β-catenin, CaMKII, protein kinase α, 
synapse-associated protein 97, and GRASP1 (Lu et al., 2017; Turimella et al., 2015).  Putative 
targets have also been identified by the presence of CPE motifs in their 3’ UTRs, including 
mRNAs encoding GluR1 and EPH receptor A4, (Turimella et al., 2015).  We reasoned that if 
CPEB2 acts as a translational regulator in vivo, then levels of CPEB2 target proteins would be 
dysregulated in CPEB2 PD-/- mice.  To test this hypothesis, western blots were prepared with 
whole brains lysates from P5 of wild type and CPEB2 PD-/- mice.  As a first step, we examined 
the levels of the GRASP1 protein, which is decreased in hippocampal cultured neurons of the 
full-CPEB2 knockout mouse (Lu et al., 2017).  However, GRASP1 protein levels were not 







Figure 3.2 Increased protein levels of CPEB2 target, CaMKIIa, in brains of CPEB2 PD-/- 
mice. Western blots of whole brain lysates were used to evaluate levels of CPEB2 target proteins 
(n=3) for each target in wild-type and CPEB2 PD-/- (A) Western blot densitometry analysis 
shows no change in the expression of CPEB2 target, GRASP1, between wild-type and CPEB2 
PD-/- animals at p5 (quantified in B). (C) CaMKIIa expression is increased in CPEB2 PD-/- mice. 
No change was observed between CPE (PSD95, GLUR1) and non-CPE (SNAP25, Tubulin) 
proteins levels in wild-type and CPEB2 PD-/- mice (quantified in D).  Data are represented as 
mean ± SEM. Statistics: (B) Student’s t-test (D) Two-way ANOVA, Bonferroni post hoc test,      
* p < 0.05.  
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To further examine how in CPEB2 PD-/- mice, loss of exon 1 alters the expression of 
proteins potentially regulated by CPEB2, the above samples were then probed for a series of 
proteins, including CaMKIIa (CPEB2 binds CAMKIIa mRNA), GluR1 (putative CPEB2 target), 
PSD95 (a CPEB3 target), and SNAP25 or synaptotagmin (synaptic proteins not associated with 
CPEB2) (Chao et al., 2013; Turimella et al., 2015).  CaMKIIa expression is increased in the 
CPEB2 PD-/- relative to wild-type mice.  The levels of PSD95, GlurR1, SNAP25 were 
unchanged between wild-type and CPEB2 PD-/- lysates (Fig 3-2C, D).  These results demonstrate 
that mice lacking exon 1 of CPEB2, specifically increases the expression of CaMKIIa.  This is an 
intriguing finding as CaMKIIa expression is required for hippocampal LTP and hippocampal 
based long-term memory (Silva, Stevens, Tonegawa, & Wang, 1992).  This finding prompted the 
next question: is CaMKIIa expression also dysregulated in the hippocampus, a brain structure 
critical for the formation of long-term memory?  
To address this question, hippocampi were dissected from p30 wild-type and CPEB2 PD-
/- mice.  Lysates were probed for CaMKIIa, GluR1, synaptotagmin, SNAP25, and tubulin.  Like 
the findings in whole-brain lysates, the CPEB2 PD-/- hippocampal lysates demonstrated an 
increase in CaMKII protein relative to wild-type mice (Fig 3-3A, B).  GluR1, synaptotagmin, 
and SNAP25 levels were unchanged from wild-type.  Together, these observations suggest that 
CPEB2 either directly or indirectly acts as a translational repressor of CAMKIIa in whole brain 
and hippocampus. Moreover, GRASP1, a protein with dysregulated expression in the global 
CPEB2 knockout, was not affected in our model.  Comparing the translation changes in complete 
CPEB2 knockout, with those in our model, allow identification of mRNA that are regulated by 








Figure 3.3 Increased protein levels of CPEB2 target, CaMKIIa, in the hippocampus of 
CPEB2 PD-/- mice. Lysates prepared from dissected hippocampus were used in western blots to 
evaluate levels of CPEB2 target proteins (n=3) for each target in wild-type and CPEB2 PD-/- (A) 
Western blot densitometry analysis shows increased expression in CaMKIIa in CPEB2 PD-/- 
animals at p30 (quantified in B). Data are represented as mean ± SEM. Two-way ANOVA, 
Bonferroni post hoc test, ** p < 0.005. 
 
CPEB2 localizes to synapses 
 
The current model suggests that CPEB proteins act as synaptic marks by inducing 
spatially targeted translational-dependent changes to the synapse.  The results outlined above 
demonstrate that CPEB2 interacts with translating mRNAs and that the CPEB2 isoform 
containing the prion-like domain likely represses translation.  However, for CPEB2 to act as a 
synaptic regulator, it must be localized at the synapse.  Although in Chapter 2, we demonstrate 
using immunofluorescence that GFP-tagged CPEB2 is present in the dendrites of hippocampal 
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neurons (Fig 2-2D), it has not been determined whether CPEB2 is located at the synapse.  The 
next experiment evaluated the subcellular distribution of CPEB2 in neurons, to resolve if CPEB2 
is found in the synapse. 
Typically, this approach would entail labeling the synapses and CPEB2 by indirect-
immunofluorescent in brain sections and examining for co-localization. However, due to the fact 
the CPEB2 specific antibody performs poorly in immunofluorescence detection of endogenous 
CPEB2 (Fig 2-4B), we turned to synaptosome purification to biochemically isolate synapses 
from brain tissue.  When brain tissue is homogenized in an isotonic solution, the pre- and post-
synaptic components are sheared away from the axons and dendrites.  Once in solution, the 
isolated membranes re-seal to form synaptosomes (Whittaker, Michaelson, & Kirkland, 1964).  
Synaptosomes have a distinct density from other cellular compartments and can be isolated by 
differential centrifugation through a sucrose gradient.  Purified synaptosomes retain the pre- and 
postsynaptic components and mimic functionally intact synapses (Whittaker, 1993).  Therefore, 
synaptosome preparations can be used to reliably investigate synaptic composition.  
Brain lysates from three-month-old of wild-type and CPEB2 PD-/- were used to purify 
synaptosomes.  Four different fractions were isolated sequentially with the following subcellular 
components: 1) cytosol and membranes, 2) nucleus, 3) cytosol and light membranes, and 4) 
synaptosomes further purified to synaptic plasma membrane (SPM) (Fig 3.4A).  After 
separation, we used western blotting to examine the proteins present in each subcellular 
compartment.  GLUR1, an AMPA receptor subunit located exclusively in synapses, was 
examined as a positive control of purified synaptic components in SPM.  Indeed, GLUR1 levels 
were rich in the SPM fraction (Fig 3.4B).  Tubulin, normally present throughout the cell, was 
found in every fraction. The transcription factor CREB, a positive control for nuclear proteins, 
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was enriched in the nuclear fraction.  Regarding CPEB2 protein, full-length protein was detected 
equally in all fractions in wild-type mice (including the SPM) (Fig 3.4B).  These results are 
consistent with the in vitro experiments described in Chapter 2 (Fig 2.2 B, C), in which GFP-
CPEB2 transfected primary neural cultures is broadly expressed, including in both the dendritic 
and axonal projections.  The synaptosomes preparations presented here demonstrate endogenous 
CPEB2 is also located in synapses.   
Figure 3.4 
 
Figure 3.4 CPEB2 is detected in synaptic fractions.  Preparation of synaptic membranes from 
wild-type and CPEB2 PD-/- brains.  (A) Diagram of synaptosome purifications protocol used to 
isolate distinct cellular fractions. Fractions in red were used for SDS-PAGE analysis. Table 
indicates cellular compartments in each fraction.  (B) CPEB2 purifies with synaptic plasma 
membrane. Western blot of cellular compartment fractions. Immunoblotted for CPEB2 and 
subcellular markers of the different cellular compartments:  GluR1 (synaptic plasma membrane), 
CREB (nuclear), and actin (loading control). GluR1 is exclusively in the synaptic plasma 
membrane, indicating successful isolation of the synaptic plasma membrane. Monomeric and 
oligomeric CPEB2 is present in all fractions including synaptic plasma membrane from wild-






CPEB2 as a translational regulator 
 
CPEB2 is an RNA-binding protein hypothesized to regulate translation by binding to the 
3’ UTR of mRNAs.  In this chapter, we establish by polysome profiling that CPEB2 exists in 
mRNA fractions undergoing all stages of translation.  Interestingly, CPEB2 is present in 
fractions containing polysome bound RNAs.  By using control gradients in which ribosomes are 
dissociated, the results show that CPEB2 is absent from the polysome fractions that contain 
mRNAs bound to multiple ribosomes.  The association of CPEB2 with mRNAs that are being 
actively translated, suggests CPEB2 acts as a translational regulator.  Does CPEB2 repress or 
activate these transcripts?  Generally, proteins that interact with polysomes and their associated 
mRNA are translational activators or elongation inhibitors that act to stall the translational 
machinery (Chen & Huang, 2012; Darnell et al., 2011).  Intriguingly, CPEB2 is proposed to be 
an elongation inhibitor. This hypothesis originates from in vitro studies demonstrating that 
CPEB2 binds to the hypoxia-inducible factor-1α (HIF-1α) mRNA in Neuro-2a cell lysates (Chen 
& Huang, 2012).  In Neuro-2a cells cultured under normoxic conditions, the longest CPEB2 
isoform binds to elongating HIF-1α mRNA and eukaryotic elongation factor 2 (eEF2).  When 
bound to CPEB2, eEF2 stalls the translation of HIF-1α by inhibiting the GTP hydrolysis required 
for translocation of the ribosome.  However, under hypoxic conditions, CPEB2 dissociates from 
the HIF-1α mRNA and removes eEF2 repression.  This novel form of regulating elongating 
mRNAs has been proposed to be a mechanism that rapidly alters translational activity in 
response to environmental stimuli.  If true, actively translating mRNAs or mRNAs stalled during 
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elongation would both be present in the polysome fractions. Our results extend these 
observations by showing in vivo that CPEB2 binds to mRNA associated with polysomes.   
To determine if CPEB2 acts as a repressor or activator, we should consider these findings 
in conjunction with our analysis of CPEB2 targets expression.  Examination of CPEB2 targets in 
the CPEB2 PD-/- model found that CAMKIIa expression is increased in the brain and 
hippocampus.  Although we cannot conclude that CAMKIIa translation is directly regulated by 
CPEB2 because we did not establish this in vitro, other groups have demonstrated CPEB2 binds 
to CAMKIIa mRNA in vitro (Turimella et al., 2015).  If indeed CPEB2 does act as translational 
regulator of CAMKIIa, our results would suggest the full length CPEB2 protein acts as a 
translational inhibitor.  In conjunction with CPEB2 being present in the polysome, CPEB2 may 
regulate the expression of CAMKIIa by acting to stall translation.  
However, CPEB2 also activates the translation of GRASP1.  Previously it was shown 
that in cultured neurons grown from the restricted CPEB2 knockout, the protein levels of 
GRASP1 are decreased (Lu et al., 2017).  We did not observe a change in GRASP1 protein in 
vivo.  Likewise, in the forebrain restricted removal of CPEB2, no changes were observed in 
CaMKIIa expression (Lu et al., 2017).  However, we assayed protein levels in vivo, while Lu et 
al., assayed protein levels in cultured hippocampal neurons.  From our own experience using 
hippocampal neurons, CAMKIIa protein levels are even more pronounced, but we did not 
examine GRASP1 using this approach.  It is difficult to reconcile these findings, since the LTP 
and memory deficit in the forebrain restricted CPEB2 knock can be rescued by viral transduction 
of GRASP1 into the hippocampus (Lu et al., 2017).  Further studies examining GRASP1 
expression in the CPEB2 PD-/- in vitro would help elucidate these differences.   
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CPEB1 and CPEB3 in mice, and Orb2/CPEB in Drosophila act as both translational 
activators and translational repressors.  As discussed in the introduction, CPEB1 acts as a 
translational activator or repressor dependent on its phosphorylation state.  Orb2 and CPEB3 
translational activity depends on their conformational state.  In both cases, the monomer 
represses translation.  But when activated and converted to its oligomeric state, these proteins 
become translational activators (Fioriti et al., 2015; Khan et al., 2015). Although CPEB2 
oligomerizes, the role of CPEB2 oligomer has yet to be determined.   
In all, if we consider that we did identify that a CPEB2 target is misregulated in the 
CPEB2 PD-/- model, we can presume that the full-length CPEB2 is required for CAMKIIa 
regulation. Further, the complete CPEB2 knockout is perinatally lethal due to translational 
repression of ChAT and likely other mRNAs. It should be noted that potentially many other 
genes are also dysregulated in this model.  However, CPEB2 PD-/- mice are viable, thus we 
hypothesize that the truncated CPEB2 protein is sufficient to maintain translational regulation 
during development. Therefore, we propose that the different CPEB2 isoforms have distinct 
effects on translation.  
   
CPEB2 localizes to the synapse 
 
The final experiments in this chapter found that CPEB2 is present at the synapse.  Using 
a synaptosome preparation, we show CPEB2 is expressed in the cytosolic, nuclear, light 
membrane, and synaptic fractions.  Observing CPEB2 expression at the synapse is critical for 
understanding CPEB2’s role in long-term memory and long-term potentiation.  CPEB3 in mice 
and apCPEB in Apylsia regulate translation at the synapse.  Like apCPEB and CPEB3, we 
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observed both the oligomer and monomer of CPEB2 at the synapse (Fig 3.4B).  However, 
because CPEB2 is expressed in multiple compartments, we were unable to determine CPEB2’s 
primary site of action.  Localization of CPEB2 to the synapse established a potential site of 
action for the experiments in the next chapter testing whether the loss of CPEB2 disrupts LTP 




Chapter 4:  CPEB2 is required for synaptic plasticity and long-term memory 
 
CPEB2 as a regulator of synaptic plasticity 
 
The results in Chapters 2 and 3 identified key features of CPEB2 that are characteristic of 
other proteins implicated in synaptic plasticity.  Chapter 3 described how CPEB2 interacts with 
translating mRNA, affects levels of proteins required for LTP, and localizes to the synapse (the 
cellular “unit” of learning and memory).  Chapter 2 provides evidence that CPEB2 is a putative 
prion-like protein, like CPEB3 or Orb2, both of which use activity-dependent prion-like 
conversions to regulate synaptic plasticity in vivo.  Indeed, full-length CPEB2 oligomerizes, yet 
when the amino acid sequence encoded by exon 1 is removed in CPEB2 PD-/-, this abrogates 
CPEB2’s oligomeric features.  
This chapter seeks to go beyond characterization of CPEB2 protein features and seeks to 
determine what role CPEB2 plays in synaptic plasticity and long-term memory in mice.  That the 
full-length CPEB2 KO is early postnatal lethal, but CPEB2 PD-/- mouse, which still produces a 
truncated form of CPEB2, has normal development and lifespan hints at CPEB2 isoforms having 
different functions in vivo. At least a truncated form of CPEB2 is sufficient to support life. An 
initial clue was apparent in the model whereby removal of full-length CPEB2 is restricted to the 
forebrain and hippocampus yields viable, developmentally normal mice. In turn, as these mice 
survived into adulthood, it became clear that a lack of full-length CPEB2 in the hippocampus led 
to disruptions in the formation of LTP and memory (Lu et al., 2017). Having identified CPEB2 
prion-like domain resides in exon 1, and CPEB2 PD-/- aging normally into adulthood, we sought 
to resolve whether CPEB2 isoform bearing the prion-like domain CPEB2 is required to support 
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LTP and memory in vivo.  Thus, we inquired whether CPEB2 PD-/- mice exhibit disrupted 
synaptic plasticity and learning. 
As a first step, we used electrophysiological hippocampal slice recordings to determine if  
synaptic plasticity in CPEB2 PD-/- mice.  Historically, hippocampal slices are the most commonly 
used model system to study LTP ex vivo because the hippocampal circuitry is well described and 
clearly visualized.  Moreover, perpendicular slices along the long axis of the hippocampus allows 
preservation of neuronal connections.  Two essential components of the hippocampal circuitry 
studied here involve the CA1 and CA3 regions. Each of these host a layer of readily visible 
pyramidal neurons.  CA3 pyramidal cells form synaptic connections with pyramidal neurons in 
CA1 stratum radiatum, via an axon bundle known as Schaffer collaterals.  The simplicity of the 
hippocampal circuit allows researchers to provide isolated stimulation to CA3 axons and record 
the responses evoked in CA1 neurons (Fig 4-1A).    
In these experiments, hippocampal slices were obtained from 1 month of age wild-type and 
CPEB2 PD-/- mice.  The slices were kept alive by superfusing with gassed artificial cerebrospinal 
fluid (ACSF).  For the recording phase, the slices were visualized under a microscope and the 
extracellular field excitatory postsynaptic potentials (fEPSPs) were monitored using a glass 
recording electrode in CA1 (Fig 4-1A).  We first measured the baseline response and excitability 
of CA1 neurons by stimulating CA3 axons with an electrode placed in the Schaffer collaterals (Fig 
4-1A). When stimulated, CA3 axons release glutamate at their synaptic connections with CA1 
neurons.  The amplitude of the fEPSP reflects the degree of activation of CA1 neurons (insets in 
Fig 4-1B).  Both the slope of the fEPSP and the fiber volley in response to stimulation of the 
Schaffer collaterals are recorded.  The fiber volley represents presynaptic action potentials in CA3 
axons evoked by the stimulus.  As the stimulation amplitude is increased, the fiber volley increases 
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as more axons are activated.  Similarly, as more axons are recruited and release more glutamate, 
the fEPSP amplitude increases.  To determine if there are differences in the Schaffer collateral–
CA1 synaptic connectivity between wild-type and CPEB2 PD-/- mice, the slope of fEPSP and fiber 
volley amplitude in the CA1 are determined at increasing strengths of CA3 stimulation.  The plots 
of fEPSP slope versus fiber volley amplitude are similar in wild-type and CPEB2 PD-/- mice and 
suggest there are no functional differences in the basic synaptic connectivity in these genotypes.  
 Next, two-types of synaptic plasticity at the Schaffer collateral-CA1 synapses were 
evaluated.  The first experiment assessed short-term plasticity.  When CA3 neurons are stimulated 
with two pulses (paired-pulses) of equal amplitude that are delivered at brief inter-pulse intervals, 
each pulse evokes a fEPSP that reflects the responses of the CA1 neurons.  If a second stimulus is 
provided within a brief interval, a stronger fESPS is generated relative to the first pulse. This 
facilitation is measured as the ratio of the response amplitudes evoked by the second stimulus to 
the first stimulus, the “paired-pulse ratio”.  A positive paired-pulse ratio indicates pair-pulse 
facilitation (PPF) occurred, a form of short-term plasticity (Zucker & Regehr, 2002).  We measured 
the paired-pulse ratio in hippocampal slices from both wild-type and CPEB2 PD-/- mice at one 
month of age.  As expected, slices from wild-type mice demonstrate positive paired-pulse ratios at 
25, 50, 75, 100, and 200ms inter-pulse intervals (Fig 4-1D). Strikingly, CPEB2 PD-/- slices fail to 
show positive pair-pulse ratios at any of the inter-pulse intervals tested (Fig 4-1D). Thus, PPF is 
absent at the Schaffer collateral-CA1 synapses in one month old CPEB2 PD-/- mice, which suggests 










Figure 4.1 Young CPEB2 PD-/- mice show decreased LTP and PPF in the hippocampus.  
Hippocampal slices were prepared from p15-p30 wild-type and CPEB2 PD-/- mice.  (A) 
Schematic representation of transverse hippocampal slice with electrodes to stimulate and record 
field excitatory postsynaptic potentials (fEPSP) from neurons in the stratum radiatum of the CA1 
region. (B)  LTP is reduced in CPEB2 PD-/- mice. fEPSP were recorded in the CA1 region after 
stimulation of Schaffer collaterals. Long-term potentiation was induced by 4 trains of 100-Hz 
high frequency stimulation (HFS) at time 0 min (black arrow). Graph is normalized fEPSP slope 
vs time. Sample traces represent average fEPSP 5 min before (grey) and last 5 mins after (black) 
HFS. Scale bars: 0.1 mV, 15 ms. (C) Magnitude of LTP is reduced in CPEB2 PD-/- mice. Graph 
of normalized fEPSP slope before and 60 min after HFS in wild-type and CPEB2 PD-/- mice 
(n=6 and n=9, respectively). (D) CPEB2 PD-/- have decreased paired pulse ratio (PPR) at 25ms 
and 50ms inter-stimulus intervals. PPR obtained induced by two consecutive stimuli delivered at 
different time intervals in wild-type and CPEB2 PD-/- mice (n=11 and n=12, respectively). (E)  
Basal synaptic transmission is intact in CPEB2 PD-/- mice.  Input–output (I–O) curves of fiber 
volley (F.V.) amplitude vs fEPSP slope relationship in wild-type and CPEB2 PD-/- mice (n=11 
and n=12, respectively). Data are represented as mean ± SEM. Normality was verified with a 
Shapiro-Wilk test. For LTP experiments results were compared using two-tailed Student’s t-test 
(α=0.05). For PPR and input-output relationship, data were compared using a two-way ANOVA 




Next, we examined whether LTP in CPEB2 PD-/- hippocampal slices is also impaired. To 
induce LTP, high-frequency stimulation (HFS) consisting of four 100 Hz stimulus trains lasting 1 
second at 30 second intervals was applied to Schaffer collaterals.  The synaptic response before 
(for 15 min) and after (for 60 min) the HFS was assessed by applying single stimulation pulses at 
0.33 Hz to the Schaffer collaterals and recording the evoked fEPSP in the stratum radiatum region 
of the CA1 (Fig 4-1B, compare before and after black arrow).  To determine if HFS induced long-
lasting synaptic potentiation (L-LTP), the baseline fEPSP responses obtained from the last 5 
minutes before HFS were compared to the responses obtained from the last 5 minutes after HFS.  
In wild-type slices, the baseline response increase to158% after HFS, indicating LTP was elicited 
(Fig 4-1B).  In CPEB2 PD-/- slices, the response increased to 120% after HFS, but this increase is 
considerably smaller ( P value) than in wild type (Fig 4-1B, C).  These results demonstrate CPEB2 
PD-/- mice have a significant LTP deficit in the CA3-CA1 synapse at one month of age.   
 Given the lack of LTP deficits in the global CPEB1-/- and CPEB4-/- mouse models, it has 
been conjectured that the CPEB1-4’s function overlaps.  Following this logic, if one member is 
removed, another might compensate for the loss of function over time. To address whether the 
LTP deficit in CPEB2 PD-/- mice is sustained over time, hippocampal CA3-CA1 plasticity was 
also assayed in aged CPEB2 PD-/- mice using hippocampal slices from six to eight-month-old 
mice.  
 The Shaffer collateral-CA1 input–output relationships were again indistinguishable in 
wild-type and CPEB2 PD-/- mice (Fig 4-2D).  At six months of age, paired-pulse ratio was again 
significantly impaired in CPEB2 PD-/- slices at 25, 50, 75 inter-pulse intervals (Fig 4-2C).  
Interestingly, the paired-pulse ratio of CPEB2 PD-/- animals was significantly higher in six-month-
old mice than was observed at one month (Fig 4-2C and Fig 4-1D).  While the CPEB PD-/- paired-
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pulse ratio is still reduced relative to the wild-type animals, the degree of the deficit decreased over 
time.  This suggests short-term plasticity in the hippocampus likely improved with age in CPEB2 
PD-/- mice. 
 LTP was also evaluated in aged animals. A normal LTP response was elicited in wild-type 
with HFS (Fig 4-2A). Strikingly, at this older age, a difference in LTP between wild type and 
CPEB2 PD-/- slices was no longer evident (Fig 4-2A, B). Thus, LTP was restored in the CPEB2 
PD-/- aged mice.  Together these results indicate oligomeric CPEB2 is necessary for mouse 
hippocampal synaptic plasticity in early life.  With age, perhaps other synaptic regulatory proteins 
normally replace CPEB2 in this role, or in the case of CPEB2 PD-/-, other protein(s) emerge to 










Figure 4.2 Aged CPEB2 PD-/- mice show intact LTP and impaired PPF in the hippocampus.  
Hippocampal slices were prepared from 6-8 months old wild-type and CPEB2 PD-/- mice. (A) 
fEPSP were recorded in the CA1 region after stimulation of Schaffer collaterals. Long-term 
potentiation was induced by 4 trains of 100-Hz high frequency stimulation (HFS) at time 0 min 
(black arrow). Graph of normalized fEPSP slope vs time. Samples traces represent average 
fEPSP at 5 min before (grey) and during last 5 mins after (black) HFS. (B) Intact LTP in aged 
CPEB2 PD-/- mice. Graph of normalized fEPSP slope before and 60 min after HFS in wild-type 
and CPEB2 PD-/- mice (n=8 and n=8, respectively). (C) CPEB2 PD-/- have decreased paired 
pulse ratio (PPR) at 25ms, 50ms, and 75ms inter-stimulus intervals. PPR obtained induced by 
two consecutive stimuli delivered at different time intervals in wild-type and aged CPEB2 PD-/- 
mice (n=12 and n=11, respectively). (D) Basal synaptic transmission is intact in aged CPEB2 
PD-/- mice.  Input–output (I–O) curve of fiber volley (F.V.) amplitude vs fEPSP slope 
relationship in wild-type and CPEB2 PD-/- mice (n=14 and n=13, respectively). Data are 
represented as mean ± SEM. For LTP experiments results were compared using a two-tailed, 
paired Student’s t-test (α=0.05). For PPR and input-output relationships results were compared 





CPEB2 PD-/- mice display impaired long-term memory  
 
The electrophysiological results demonstrate that exon 1 of CPEB2 is required for synaptic 
plasticity in young mice.  We hypothesized that young CPEB2 PD-/- mice should exhibit 
impairments in behavioral learning and memory tasks.  Given that CPEB2 PD-/- synaptic plasticity 
deficits were identified in the hippocampus, we used two hippocampal-dependent behavioral 
paradigms that test long-term memory: 1) contextual inhibitory avoidance and 2) Morris water 
maze. 
To correctly interpret these memory-dependent behavioral tests, we first determined 
whether knocking out the CPEB2 prion-like domain results in motor deficits or other behavioral 
changes. To this end, we used the open-field test (OFT) to assay general locomotor performance 
and anxiety levels in CPEB2 PD-/- mice.  The open-field test consists of a large box apparatus with 
a brightly illuminated center field (Fig 4-3A).  Mice are placed in the apparatus for ten minutes 
and their velocity and location relative to the center are recorded to assess for motor deficits (Fig 
4-3A).  Mice naturally avoid open and well-lit areas where they might be visible to predators.  
Therefore, when placed in the open field arena, mice display a balance between avoiding the open 
field and exploring a new environment (Crawley, 2008; Hitzemann, 2000; Post et al., 2011).  In 
the OFT, mouse models with increased anxiety avoid exploring the open field near the center of 







Figure 4.3 CPEB2 PD-/- mice exhibit motor deficit but do not display increased anxiety in 
open-field test. Open field test at 3 months of age for CPEB2 PD-/- and wild-type littermates 
(mice n=6 and n=8 respectively). (A) Schematic of zones in open field area.  (B) Cumulative 
heat maps depict the time and movement spent in open field arena across all trials for wild-type 
and CPEB2 PD-/- mice. Color maps indicates mice spent increased time in a particular area, with 
red more and blue less time (C) CPEB2 PD-/- mice travel less than wild-type mice.  (D) CPEB2 
PD-/- mice have lower average velocity than wild-type mice. (E and F) CPEB2 PD-/- mice 
exhibit normal anxiety (E) CPEB2 PD-/- and wild-type mice enter the center zone with the same 
frequency.  (F) CPEB2 PD-/- and wild-type mice spend similar amounts of time in the center 




In the OFT, both wild-type and CPEB PD-/- mice display preference for the edges of the 
box (Fig 4-3B, the red indicates the areas where mice were located the majority of the test).  
Interestingly, CPEB2 PD-/- mice travel significantly less than wild-type mice (Fig 4-3C) and this 
likely accounts for their reduced velocity (18%) (Fig 4-3D).  Concerning the possibility of an 
anxiety phenotype, the number of times the mice entered the center of the box or the percent time 
spent inside the center was not statically significant between genotypes (Fig 4-3E, F).  Given the 
animals similarly explore the center of the box (a novel area), the decrease in locomotion observed 
in CPEB2 PD-/- mice is less likely to be due to increased anxiety levels. However, the reduced 
travel distance suggests CPEB2 PD-/- mice may have a mild locomotor impairment.   
The first test of long-term memory formation and persistence, we used a modified 
contextual fear conditioning paradigm (CFC).  This involves learning contextual information and 
emotional information.  The apparatus consists of a chamber with a brightly illuminated open 
field connected to a dark shock compartment (Fig 4-4A).  The paradigm trains mice to form a 
stable association between the dark compartment (context) and a noxious stimulus (foot shock) 
(Curzon, Rustay, & Browman, 2009; Huff, Emmons, Narayanan, & LaLumiere, 2016; Wehner 
& Radcliffe, 2004).  On the first day of training, the mouse is placed in the illuminated side of 
the apparatus.  The mouse’s natural behavior is to retreat into the dark compartment.  When the 
mouse enters the dark compartment, the animal receives a mild foot shock and is immediately 
removed from the dark chamber.  The foot shock establishes a negative relationship between the 
comforting (dark) space and a negative stimulus (shock).  It has been well-established that 
contextual fear conditioning is a form of learning dependent on the hippocampus and amygdala 
(Phillips & LeDoux, 1992). To determine if the mouse has formed a long-term memory of the 
incident, the mouse is returned to the illuminated chamber 48 hours later, and the latency of the 
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mouse to cross into the dark compartment recorded.  If the mouse has formed a strong 
association between the dark compartment and the shock stimulus, the animal avoids returning to 
the dark compartment, despite the instinctual unlearned drive to do so. The longer it takes for the 
animal to enter the dark compartment indicates a stronger memory.  The “strength” of this 
memory can be reassessed over time, without additional training, by returning the mouse to the 
same illuminated chamber (Fig 4-4B).  
Using this paradigm, we assessed long-term memory formation in 2-3 months of age 
CPEB2 PD-/- mice and their wild-type littermates. When returned to the illuminated chamber 48 
hours after training, wild-type animals appropriately avoid re-entering the dark compartment 
(average latency of 560 ± 148s, SD) (Fig 4-4C).  Strikingly, CPEB2 PD-/- mice more readily 
enter the dark chamber, with a significantly reduced latency-to-enter compared to wild-type 
controls (average latency of 342 ± 239s, SD) (Fig 4-4C).  These results show that CPEB2 PD-/- 
mice have a decreased ability to form long-term memory compared to wild-type littermates.  To 
test the stability of this memory, the latencies were also measured at one week, two weeks, one 
month, and two months after initial training.  Across all additional time points, wild-type animals 
demonstrate greater latencies (>400s) than CPEB2 PD-/- mice (<280s) (Fig 4-4C).  For a control, 
we undertook a mock training phase in which wild-type and CPEB2 PD-/- mice performed the 
task without receiving the foot shock when they entered the dark compartment.  After the mock 
training, wild-type and CPEB2 PD-/- mice tested at 48 hours, one week, two weeks, and one 
month show no avoidance of the dark compartment (Fig 4-4D).  Together these findings suggest 








Figure 4.4 Long-term contextual memory deficit in CPEB2 PD-/- mice.  Modified contextual 
fear conditioning (CF) test of CPEB2 PD-/- mice and wild-type littermates at 3 months of age 
(mice n=7 and n=8 respectively).  (A) Diagram of inhibitory avoidance apparatus used in 
modified CFC.  (B)  Schematic of the training paradigm for behavior training and memory 
testing.  (C) Retention impairment in CPEB2 PD-/- mice. Inhibitory avoidance behavior was 
assayed by recording the latency for each mouse to cross into the dark chamber. Graph of the 
latency for each group in which greater retention latencies indicate more stable memory. CPEB2 
PD-/- mice exhibit decreased retention latencies at 48 hours, 1 week, 2 weeks, and 2 months after 
footshock training.  (D) Mice received mock training on day 1 with no footshock. Neither 
genotype avoided entering into the dark compartment. Data are represented as mean ± SEM. 
Data were compared using a two-way ANOVA with Holm-Sidak post hoc. Statistical differences 




The CFC paradigm uses a short one-day training period that produces a robust long-
lasting memory.  We next asked whether CPEB2 PD-/- mice could form long-term memory in 
another hippocampal based memory paradigm, the Morris water maze (MWM), which uses a 
longer and more robust training period (Morris, 1984).  The MWM consists of circular pool of 
water surrounded on each axis by four large distal visual cues.  An accessible submerged hidden 
platform is in one quadrant of the pool (called the platform zone) (Fig 4-5A).  The MWM tests 
spatial learning by training the mice to use distal cues to form a hippocampal-dependent map of 
the location of the submerged platform (Vorhees & Williams, 2006).  The spatial map is formed 
during repeated training trials when the mice are placed in different starting locations in the pool.  
During the three days of training a normal mouse learns the location of the hidden platform 
relative to the distal cues (Fig 4-5B).  Each day, the mice are trained with four two-minute trials 
from predetermined starting positions. after three days of training, long-term spatial memory is 
assessed in a probe trial given 24 hours later.  After the training period, the spatial learning is 
measured by removing the hidden platform.  Mice that generated a strong spatial map will spend 
the majority of the probe time searching the target quadrant (TQ) that previously contained the 
platform.   
 Using this paradigm, we assessed the ability of 2-3 months of age CPEB2 PD-/- mice and 
their wild-type littermates to form-long term memory.  As a measure of long-term memory, we 
first determined the escape latency, the time required for the mouse to reach the platform with 
training.  Both genotypes demonstrate normal learning acquisition, with a daily improvement in 
the ability to locate the platform on each successive day of training (Fig 4-5C).  On the first 
probe trial, wild-type mice have a moderate preference for the TQ, while the CPEB2 PD-/- mice 
do not.  However, there was no statistical difference between the two genotypes for the duration 
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of the time spent in TQ (Fig 4-5D, comparing TQ duration of both genotypes).  After three 
additional trainings, a second probe trial was given. The second probe trial show that both wild-
type and CPEB2 PD-/- mice are able to form a statistically significant preference for the time 
spent in TQ (Fig 4-5E). Again, there was no difference between genotypes (Fig 4-5E). A more 
precise measure of hippocampal-dependent spatial map formation is based on analyzing the 
animals’ searching patterns, quantifying the occupancy time in the area immediately above the 
platform, the platform zone (Nakazawa et al., 2002).  During the first probe trial, CPEB2 PD-/- 
mice spend significantly less time searching in the platform zone compared to wild-type (Fig 4-
5F, G).  With additional training, wild-type and CPEB2 PD-/- mice spend the same amount of 
time searching for the platform zone (Fig 4-5G).  The hippocampal memory-dependent special 
tasks presented here suggest CPEB2 PD-/- mice have moderately impaired memory recall in the 










Figure 4.5 Intact learning and minor spatial memory deficit in CPEB2 PD-/- mice. Morris 
water maze (MWM) spatial memory task of CPEB2 PD-/- mice and wild-type littermates at 2-3 
months of age (mice n=18 and n=17 respectively). (A) Image of MWM with labeled quadrants. 
Location of submerged platform is shown by grey square.  (B) Diagram of MWM training and 
memory testing paradigm. Training days consisted of four two-minute trials per day with the 
platform place in the pool. Memory recall was assayed on days 4 and 9 by removing the platform 
and recording the mouse’s position for 60 seconds. (C) Wild-type and CPEB2 PD-/- mice 
normally learned in the location of submerged platform within three days of training.  Graphed is 
the average time each genotype took to find the platform on the first trial of each training day.  
(D) In the first probe trial, the platform was removed, and the percentage of time the mouse spent 
in each quadrant was recorded. Neither genotype showed a strong preference for the quadrant 
that previously contained the platform (TQ). (E) After three days of additional training, a second 
probe trial was performed.  Both wild-type mice and CPEB2 PD-/- mice spent increased time 
searching the TQ where the platform was previously placed.  (F) Cumulative heat maps from all 
trials of the searching patterns during both probe trials.  Red box depicts exact location of 
previous platform (platform zona), as opposed to the quadrant with the platform (TQ).  
Quantified in G. (G) During probe, CPEB2 PD-/- mice search longer directly over the previous 
platform zone.  Graphed is the average number of seconds the mice spend in platform zone for 
both genotype during probe 1 and 2.  Data were compared using a two-way ANOVA with 







This chapter describes two important phenotypes resulting from the loss of CPEB2 PD in mice. 
At the circuit level, CPEB2 PD-/- mice exhibit a severe age-dependent LTP deficit.  In behavioral 
testing, CPEB2 PD-/- mice display a pronounced long-term memory impairment in contextual 
fear conditioning and a moderate memory recall impairment in the Morris water maze. 
 
CPEB2 is required for early age synaptic plasticity 
 
Electrophysiological experiments using mouse hippocampal slices show that at 1 month 
of age, CPEB2 PD-/- lack both PPF and LTP.  Paired pulse facilitation (PPF) is a form of 
activity-dependent synaptic plasticity that results when residual calcium in the axon terminal 
produced by the first pulse augments the response generated by the second pulse (L. G. Wu & 
Saggau, 1994).  PPF is thought to serve as a mechanism for simple learning and rapid 
information processing (Fisher, Fischer, & Carew, 1997; Fortune & Rose, 2001).  Originally, it 
was proposed that two key presynaptic factors regulate paired-pulse plasticity: the ready 
releasable pool of presynaptic vesicles (Rizzoli & Betz, 2005) and the calcium levels in the 
presynaptic terminal (Fioravante & Regehr, 2011).  However, other studies argue that PPF also 
involves post-synaptic changes consisting of alterations in the number of available AMPA 
receptors at the post-synaptic site (Rozov & Burnashev, 1999; Rozov, Zilberter, Wollmuth, & 
Burnashev, 1998). Intriguingly, activated CAMKIIa works to stimulates AMPA receptor 
tracking to the post-synaptic membrane (Maletic-Savatic, Koothan, & Malinow, 1998).  In 
Chapter 3, we demonstrate that CPEB2 PD KO-/- mice have increased levels of CAMKIIa, but do 
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not have altered levels of the AMPA receptor subunit, GluR1.  Overall, we show that the CPEB2 
containing amino acid sequence encoded by exon 1 is required to generate PPF in both young 
and aged mice and this is not rescued by production of truncated CPEB2.   
Young CPEB2 PD-/- mice show a deficit in LTP.  High frequency stimulation in 1 month 
old CPEB2 PD-/- mice results in a dramatic reduction in L-LTP compared to wild-type controls.  
These findings indicate CPEB2 is required for early-age LTP.  Curiously, synaptic plasticity was 
restored in older CPEB2 PD-/- mice.  At six months, CPEB2 PD-/- mice exhibit normal LTP and 
only moderately reduced PPF.  The loss of early-age LTP may be due to changes in protein 
expression in neurons.  We found increased levels of CAMKIIa protein in the CPEB2 PD-/- 
hippocampus.  CAMKIIa is critical for LTP in young and adult animals (Wang et al., 2003).  We 
also find that the recovery of LTP correlates with a recovery in CAMKIIa levels in the CPEB2 
PD-/- adult mice (Appendix 2 A, B).  The formation of LTP requires local translation of 
CAMKIIa mRNA in dendrites and synapses (Aakalu, Smith, Nguyen, Jiang, & Schuman, 2001; 
Miller et al., 2002) and CAMKIIa mRNA binds CPEB2 protein in-vitro (Turimella et al., 2015).  
Therefore, we propose that the alteration of CAMKIIa in CPEB2 PD-/-, possibly through 
translational dysregulation, contributes to the LTP deficit in young mice. 
To our knowledge, the CPEB2 PD-/- is the only mouse model that displays an age-
dependent loss of LTP, being deficient in early life and restored later in adulthood.  There are 
two possible explanations, 1) CPEB2 is required for synaptic plasticity in young mice, but not at 
six months of age or 2) other CPEB family members compensate for the loss of CPEB2 protein. 
One way to differentiate these two explanations is by examining the levels of CPEB2 expression. 
For example, normal loss of CPEB2 expression in aged wild-type mice would suggest CPEB2 is 
not required for adult LTP.  However, we did not observe explicit differences in CPEB2 
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monomeric or oligomeric protein levels between young and aged wild-type mice, implying that 
other mechanisms are responsible for LTP recovery.  An alternative mechanism is compensation 
by other CPEB family members with aging.  In support of this possibility, the RNA binding 
domains of CPEB2-4 are 96% similar (Tsai et al., 2013), and the distinct CPEB family members 
bind the same mRNAs (Turimella et al., 2015).  Global CPEB1 knockout mice display a LTP 
deficit with a weak stimulation protocol but normal LTP with strong stimulation protocols 
(Alarcon et al., 2004).  The authors speculated that with stronger stimulation, other readily 
available CPEB proteins are recruited and compensate for the missing CPEB1.  Regarding 
CPEB3, when it was knocked out from all tissues, the investigators found no LTP deficits (Chao 
et al., 2013).  Yet when CPEB3 is selectively knocked out from the hippocampus, cortex, 
amygdala, LTP deficits were reported (Fioriti et al., 2015).  Either through developmental 
changes or with greater activation, it appears that loss of CPEB function can be compensated for.  
As we do not find an increase in CPEB3 levels with age in the CPEB2 PD-/- mice (Fig 2-5A), we 
suggest that other CPEB family members compensate for the loss of CPEB2 with age.   
These findings demonstrate the longest CPEB2 isoform is required for both PPF and LTP 
in young mice.  It is notable that while the PPF does improve in aged CPEB2 PD-/- mice, it 
remains significantly reduced relative to wild-type.  Homozygous knockout models of the RNA-
binding protein, Ataxin-1, and heterozygous knockouts of CAMKII also demonstrate deficits in 
PPF with intact LTP (Matilla et al., 1998; Silva et al., 1996).  These studies suggest that proper 
PPF is not required for the formation of LTP.  However, our findings suggest that CPEB2 is 
capable of disrupting pathways required for both PPF and LTP in an age-dependent manner.  
Therefore, with further study, the CPEB2 PD-/- model could provide additional insights into 
understanding how these distinct forms of plasticity are regulated.   
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CPEB2 is required for long-term memory 
 
 We inquired whether disrupted PPF and LTP in CPEB2 PD-/- mice was reflected in 
behavioral correlates using two long-term memory paradigms.  In the contextual fear condition 
paradigm, we found that CPEB2 PD-/- mice do not form a strong memory between a contextual 
conditioned stimulus and an unconditioned (learned) noxious stimulus and this memory deficit 
persists up to two months after training.  Hippocampal-dependent long-term memory can be 
subdivided into two subcategories: spatial and contextual. These findings suggest that CPEB2 
PD-/- mice are unable to form context-based long-term memories. Interestingly, in CPEB2 PD-/- 
mice although there is significant reduction in memory, the memory that was formed persisted 
for at least two months. These results suggest there are CPEB2 independent pathway that are 
sufficient to form some low level but stable memory. We speculate that in aged animals, similar 
pathways may also explain the lack of memory phenotype.   
A less robust phenotype was observed in the Morris water maze. Wild-type animals 
performed better early in the task (probe 1), but with additional training the performance of 
CPEB2 PD-/- mice became virtually indistinguishable from wild-type controls (probe 2).  This 
indicates long-term spatial memory formation was delayed in the CPEB2 PD-/- mice. However, 
given that CPEB2 PD-/- mice perform close to wild-type levels on all but one of the MWM 
measures, we speculate that spatial tasks are less dependent on CPEB2.  These seemingly 
contradictory findings are intriguing, as CPEB2 PD-/- mice exhibit a strong deficit in the CFC 
task.  While the MWM is thought to be strongly dependent upon the hippocampus, several 
reports have demonstrated impaired or absent CA1 LTP with normal spatial learning (Meiri, 
Sun, Segal, & Alkon, 1998; Montkowski & Holsboer, 1997; Zamanillo et al., 1999).  However, 
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CFC requires both the amygdala and hippocampus (Phillips & LeDoux, 1992; Tayler, Tanaka, 
Reijmers, & Wiltgen, 2013).  The differences in performance between these two tasks suggests 
the role of CPEB2 in CFC may involve the amygdala.  In CPEB2 PD-/- mice, CPEB2 was 
removed from all tissues and CPEB2 function is likely critical in other brain regions, including 
the amygdala. In summary, the results presented in this chapter demonstrate that the CPEB2 
containing the prion-like domain is required for synaptic plasticity and contextual long-term 








The body of work presented in this thesis suggest that CPEB2 is a putative prion-like 
protein and an essential molecule required for both synaptic plasticity and some form of long-
term memory.  This thesis project began by asking whether the four different CPEB genes 
contain the sequences found in a novel class of yeast prion-like proteins.  We found that relative 
to the entire proteome, CPEB2-4 are rich in prion-like sequences.  CPEB2 stood out with the 
highest degree of similarity to other known prion-like proteins.  Further, the CPEB2 prion-like 
domain is encoded by exon 1, and the CPEB2-204 isoform contains this sequence.  In the initial 
biochemical and immunofluorescent experiments we show that CPEB2 forms SDS-resistant 
higher order structures and aggregates in both cultured tissue cells and primary neuronal cultures.  
 Based on these findings, we generated an isoform specific CPEB2 knockout model that 
specifically lacked the exon 1 containing the putative prion-domain (CPEB2 PD-/-).  Our 
biochemical studies reveal that the CPEB2 PD-/- mice produce a truncated CPEB2 transcript and 
protein. Indeed, using CPEB2 PD-/- P5 brain samples, we observed a protein band that likely 
corresponds to the smallest endogenous CPEB2 isoform (CPEB2-202).  The presence of both 
CPEB2 mRNA transcripts and proteins suggests the CPEB2 PD-/- is a specific isoform knockout. 
Despite previous observations that a global knockout of all CPEB2 isoforms is lethal in the 
perinatal period, global CPEB2 PD knockout mice are viable and healthy (Lai et al., 2016).  We 
conclude that the sequence encoded by CPEB2 exon 1 is not required for CPEB2 functions 
critical for development.  
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 An inadvertent finding is that this smallest CPEB2 isoform is likely required to sustain 
life in early development, via an unknown mechanism.  Death of complete CPEB2 knockout 
mice is attributed to severe bronchoconstriction due to hyper-activation of parasympathetic 
neurons (Lai et al., 2016).  As discussed in more detail in Chapter 1, these investigators provided 
evidence to support a mechanism whereby CPEB2 represses the translation of choline 
acetyltransferase (ChAT), and hyper-activation of parasympathetic neurons ensues.  Our results 
suggest that CPEB2-dependent life-sustaining pathways depend on the shorter CPEB2-202, not 
the full-length CPEB2-204 removed in the CPEB2 PD KO model.  
 To date, removal of CPEB2 alters the level of at least three different proteins studied: 1) 
global CPEB2 knockout increases the ChAT expression, 2) forebrain restricted CPEB2 removal 
activates GRASP1 expression, and 3) removal of CPEB-204 (exon 1 and the prion-like domain) 
increases CAMKIIa expression.  Furthermore, CPEB2 binds to each of the mRNAs transcripts of 
ChAT, GRASP1, and CAMKIIa.  However, because we have not demonstrated in-vitro that 
CPEB2 directly regulates CAMKIIa, we cannot exclude the possibility that CAMKIIa expression 
is dysregulated due to other changes inside the neuron.  It should be noted that the forebrain 
restricted CPEB2 knockouts do not have changes in CAMKIIa expression (Lu et al., 2017).  In 
our model, increased CAMKIIa expression seems to ensue from the absence of the CPEB2-204, 
not GRASP1 loss.  
It has been proposed CPE-mediated translation is regulated by the number of CPEs in the 
3’UTR.  In Xenopus, CPEB1-dependent translation of cyclin B is modulated by altering the 
position and number of CPEs (Pique, Lopez, Foissac, Guigo, & Mendez, 2008).  The findings 
presented in this thesis introduces another layer of translational regulation in the nervous system 
by these regulatory proteins, whereby distinct CPEB2 isoforms modulate translation of different 
	
	 83	
target mRNAs.  Because CaMKIIa expression is enhanced in the CPEB2 PD-/-, we conclude that 
the full-length CPEB2-204 isoform containing exon 1 is necessary at least for the regulation of 
CamKIIa expression. Correspondingly, CPEB2-202 is required for survival during the neonatal 
period.  These findings suggest a model in which individual CPEB2 isoforms differentially 
regulate translation either by binding different targets or by differential time expression or cell 
specific expression.  
It is intriguing to consider our findings in conjunction with results demonstrating that 
alternative-splicing regulates the expression of protein isoforms in a tissue specific manner 
(Jensen et al., 2000).  One possible mechanism to account for differential expression of CPEB2 
isoforms is by the splicing regulatory protein, Nova-1. CPEB2 contains a Nova-1 binding motif 
in the sequence encoded by exon 1.  Nova-1 is an RNA-binding protein that is developmentally 
expressed in a subset of neurons in the brainstem, hypothalamus, and spinal cord (Buckanovich, 
Posner, & Darnell, 1993).  It has been shown that Nova-1 is a splicing factor that promotes 
alternative splicing by binding to the pre-mRNA’s containing a Nova binding site and recruiting 
the spliceosomal complex (Ule et al., 2006).  It remains to be determined whether CPEB2 is 
regulated by Nova-1.  However, the possibility is consistent with the observation that juvenile 
and adult neurons and glia in the hippocampus express different combinations of the CPEB2 
isoforms (Turimella et al., 2015).  Considering that many genes contain binding sites for CPEB2 
in their 3’ UTRs and that CPEB2 is required for different functions, it is likely that CPEB2 
expression is highly regulated (Chen & Huang, 2012; Chen et al., 2015; Lai et al., 2016; Lu et 
al., 2017).  Future experiments in-vivo are needed to determine if CPEB2 cell-specific expression 




Our findings also demonstrate that CPEB2-204 is critical for synaptic plasticity and long-
term memory.  While it was previous established that forebrain restricted removal of CPEB2 is 
required for LTP and long-term memory, the results in this thesis provide the novel insight that 
the CPEB2-204 isoform containing exon 1 and its prion-like domain are critical for this 
phenotype.  The CPEB2 PD-/- model has severely disrupted PPF and LTP in organotypic 
hippocampal slices isolated from young mice.  In line with the loss of PPF and reduction in LTP, 
CPEB2 PD-/- mice show contextual and spatial learning disruptions at a young age.  Therefore, 
we conclude that full-length, oligomeric, CPEB2 plays a critical functional role in the regulation 
synaptic plasticity and the formation of long-term memory. 
A primary objective of this thesis was to explore whether other CPEB family members 
use prion-like mechanisms for their function as observed with CPEB3.  We performed 
experiments to determine if CPEB2-204 is a putative prion-like protein.  Using SDS-AGE shows 
that full-length CPEB2 forms SDS-resistant oligomers that are resistant to reduction by DTT.  
The oligomers are present throughout the lifespan and localize to the synapse.  In contrast, when 
the prion-like domain of CPEB2 encoded within exon 1 is removed, the oligomers are no longer 
evident. This implies that the protein sequence encoded by exon 1 is required for the formation 
of CPEB2 high-order assemblies.  Following these observations, we propose that CPEB2 is 
putative-prion like protein.  While further study is required, we show clearly that, paralleling 
prion-like proteins, CPEB2 forms higher order structures in-vivo.   
What is the function of CPEB2 oligomers?  It has been proposed similar structures serve 
as synaptic tags that are induced with neuronal activity.  Best studied for the synaptic protein 
CPEB/Orb2 in Drosophila, in its monomeric state Orb2 acts to repress genes required for 
synaptic growth.  Upon stimulation Orb2 converts into its prion-like oligomer conformation and 
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switches from a translational repressor to a translational activator (Khan et al., 2015; L. Li et al., 
2016; Majumdar et al., 2012).  The prion-like conformation of Orb2 induces the conversion of 
other monomeric Orb2 protein into prion-like states, leading to the model in which the 
amyloidogenic Orb2 functions as a synaptic tag at activated synapses due to oligomers ability to 
self-perpetuate and maintain synapses for long period of time.  The significance of this 
oligomeric conversion becomes clear when Orb2, a protein whose function is required for long-
term memory, is restricted to its monomeric state.  Several experiments show that flies cannot 
form long term memories if Orb2 cannot form oligomers either by reducing its rate of oligomeric 
conversion, selectively cleaving the oligomeric protein, or by removing the prion-like domain 
from the endogenous locus, (Keleman et al., 2007; Majumdar et al., 2012).  Given these findings, 
it was concluded that prion-like oligomers are critical for Orb2’s role in memory. 
Our results demonstrate CPEB2 meets several criteria shared with other established 
prion-like proteins, 1) CPEB2 forms SDS-resistant oligomers, 2) CPEB2 oligomers are present at 
the synapse, 3) CPEB2 oligomers associate with Q/N rich sequences, and 4) CPEB2 depends on 
the prion-like domain to fulfill its role in synaptic plasticity and long-term memory. An 
important limitation in our experiments is they did not discern whether the prion-domain is 
specifically required for LTP and memory, since exon 1 may be involved in other necessary 
functions.  Intriguingly, the role of full-length CPEB2 in memory is clearly different from those 
of CPEB3 and Orb2.  Despite that CPEB3 and Orb2 are required for the maintenance of 
memory, our results show CPEB2 PD-/- mice form as stable a memory as wild-type mice in 
contextual fear conditioning experiments.  Conversely, in this task CPEB2 PD KO-/- mice do not 
form as strong of a memory as wild-type mice.  This suggests CPEB2 and CPEB3 are required at 
different phases of memory formation.  In summary, we present that CPEB2-204 is an essential 
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isoform required for the formation of LTP and long-term contextual memory in young mice, and 






Uncovering new gene pathways associated with CPEB2 
 
One of our ongoing studies is analyzing the effect of removing CPEB2 from the nervous 
system on the translatome.  The thesis demonstrates CPEB2 associates with translating mRNAs.  
To determine which RNAs CPEB2 regulates, we plan to isolate the polysome bound mRNAs 
from both wild-type and CPEB2 PD-/- mice.  The RNAs found in these fractions will be 
evaluated by next-generation RNA sequencing (Hitzemann et al., 2014).   These experiments 
will provide additional insights on the translational changes that emerge as a consequence of loss 
of full-length CPEB2.  We expect that comparing these two genotypes will reveal which changes 
in gene expression or pathways associated with synaptic plasticity and long-term memory, with 
the potential to uncover new translation changes not previously associated with synaptic 
plasticity.   
Because synaptic plasticity the CPEB2 PD-/- synaptic deficits are restricted to young 
mice, we will compare these results with RNA-sequencing analysis of polysome mRNA on six-
month-old wild-type and CPEB2 mice. This additional analysis is designed to uncover changes 
between the young and adult CPEB2 PD-/- mice without LTP deficits.  The goal is to identify if 
particular translational changes are associated with the recovery of LTP.  One caveat of this 
experiment is that translational changes associated with normal aging, which will need to be 
discerned.  However, with inclusion of the wild-type mice dataset, we hope to isolate the aging 




CPEB2’s role in memory 
 
 Our initial studies establish that CPEB2 is required for the formation of long-term 
memory.  Moving forward there are two important questions to answer, 1) does long-term 
memory recover with age and, 2) during which phase of memory formation is CPEB2 necessary?  
Due to the fact that LTP and PPF recover by six months in CPEB2 PD-/- mice, we will assay the 
ability of aged CPEB2 PD-/- mice to form long-term memory using the CFC.  Our hypothesis is 
that CFC memory will recover.  Establishing this will allow us to make better comparisons 
between the transcriptional pathways observed in the CPEB2 PD-/- mice.  Second, we plan to 
evaluate when CPEB2 expression is necessary for long-term memory formation.  The approach 
will build on our previous genetic manipulation of removing exon 1 from CPEB2 by using a 
conditional CPEB2 knockout mouse model with LoxP sites in the intronic regions flanking exon 
1.  This model has been established by our laboratory.  Using this model, we can test when 
CPEB2 expression is necessary for memory by selectively removing CPEB2, either during or 
after training.  Results from the CPEB2 PD-/- model suggest CPEB2 is required for the initial 
memory formation.  However, CPEB2 might be necessary for memory recall as well.  To test 
this, we will remove CPEB2 expression by viral transduction in the hippocampus, either before 
or immediately after training.  After the induction, memory paradigms can be used to test when 
CPEB2 expression is necessary for long-term memory formation.  A potential confounds to this 
experiment is it that viral transduction requires days or weeks to occur, thus limiting to assaying 
the effect of removing only to the later time points.  These experiments would help clarify the 




CHAPTER 6: Materials and methods  
 
PLAAC and SEQ analysis  
PLAAC analysis of CPEB proteins and mouse proteome protein and was performed using the 
web based application (http://plaac.wi.mit.edu/).  The PLAAC application scans the input protein 
sequence for amino acid compositions found in previously identified prion-like domains. Each 
amino acid is ranked for two states: prion-like or background using a hidden Markov model 
(Alberti et al., 2009). The states are based upon the amino acid frequencies found in the prion-
like domains of yeast prion proteins. For our analysis, we set the minimum core length of the 
prion-like domain to 100 and scanned for prion-like sequence similarity using the S.Cerevisiae 
background frequencies. We input the mouse reference protein (UP000000589), containing all 
protein isoforms (including CPEB1-4) into the PLAAC application.  From the output generated, 
we collected the LLR score (prion-like score) for each isoform, which is the log-likelihood ratios 
that the sequence is present in the prion-like state.  Thus, the prion-like score indicates the degree 
to which the protein sequence is found in the prion-like state of the algorithm.  The LLR score 
was used for further analysis. For identifying the particular sequence which contained a predicted 
prion-like domain in the different CPEB genes, PLAAC analysis was also used.  
 
SEQ analysis was performed using SEQ plug-in filter of NCBI BLAST web based application 
(https://blast.ncbi.nlm.nih.gov/Blast.cgi).  Using this approach, low-complexity sequence is 
identified based on the algorithm by Wootton and Federhen (Wootton and Federhen., 1993). The 
application identifies low-complexity sequence in the input sequence and scores the amount of 
lox-complexity sequence relative to total sequence length.  For our analysis, we input the mouse 
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reference protein (UP000000589), containing all protein isoforms (including CPEB1-4) into the 
SEQ plug-in of NCBI BLAST.  Each protein isoform was scored for the amount of lox-
complexity sequence.  The low-complexity score was used for further analysis.   
 
Mice 
The Institutional Animal Care and Use Committee approved all animal use protocols. All mice 
were housed and managed by Research Animal Resources under SPF conditions in an 
AAALAC-approved facility. CPEB2 PD mice were genotyped using the following primers:  
forward:  ctgctgacgcacgttcc, reverse: caaactccagaagggaacaac. For behavioral experiments, 
CPEB2 PD-/- and wild-type littermates were obtained using heterozygous CPEB2 PD+/- crosses.  
For hippocampal cultures and slices, wild-type controls were obtained from crosses of CPEB2 
PD+/+, and experimental groups were obtained from crosses of CPEB2 PD-/-. 
 
Generation of CPEB PD-/- model 
Guide RNAs were targeted against the 3’ and 5’ intronic regions of CPEB2 exon 1. Guide RNA 
sequence was designed using CRISPR Design online tool (http://crispr.mit.edu/).  The guide 
RNA sequences that were used are as follows:  5’ –acggggtgcgtctcctgccg; 3’ – 
ggagcgcccggggcgttcga. To ensure proper targeting to the CPEB2 introns, we first PCR amplified 
(Q5 Hotstart HiFi, New England Biosciences Cat No. M0493L, Ipswich, Massachusetts) the 
region surrounding each of the guide sites using the following primers pairs 5’ ctgctgacgcacgttcc 
and 3’ caaactccagaagggaacaac. The PCR product was cleaned and sequenced using the same 
primers that were used in the amplification. The guide sites were confirmed in the sequence, and 
there was no evidence of endogenous SNPs that would prevent target binding. The guide 
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sequences where then ordered as synthesized oligonucleotides (IDT) and cloned into the 
pSpCas9 plasmid (Addgene: px330) and sequence verified. The guide plasmids were then 
injected at (3ng/ul) into single cell F1c embryos, implanted into pseudo pregnant females (strain: 
CBA/CaJ x C57BL/10), and allowed to develop to term. Once mice were born and weaned tail 
samples were taken. Genomic DNA from tail samples were purified in a Promega Maxwell 16 
using the Tissue DNA Kit (Promega Cat No. AS1030, Madison, Wisconsin). PCR was 
performed using primer pairs 5’ ctgctgacgcacgttcc and 3’ gcccagctcaggacaaa to identify founders 
with a deletion of exon 1. Two mice were positive for a deletion that occurred from the cut site 
of the 5` guide to the cut site of the 3` guide (1690bp deletion).  One of these founders 
transmitted the deletion to germline and produced positive F1 pups. This line established the 
CPEB2 PD mouse model.   
 
RNA isolation 
Total RNA was isolated from the whole brains using TRIzol reagent (Life Technologies Cat 
No.15596-018, Carlsbad, California).  Brains were homogenized in 1ml TRIzol using motorized 
pestles for 1 minute each.  RNA isolation was completed following manufacturers protocol.  




cDNA synthesis was performed using PrimeScript First Strand cDNA Synthesis Kit (Takara Bio 
USA Cat no. 6110A, Mountain View, California) using random hexamers following 




Reverse transcriptase coupled PCR (RT-PCR) 
RT-PCR experiments were performed using cDNA synthesized from total brain mRNA.  PCR 
was performed using Q5 Hotstart HiFi (New England Biosciences Cat no. M0493L, Ipswich, 
Massachusetts) following the manufactures protocol. To assay the presence of each exon in the 
CPEB2 PD-/- mice, PCR paired each of the following primer sequences: 5’ cgcccgccatgaatttac, 
ccgccatgaatttacctcaac, gccgttctcgggtaatgttat, with 3’ ctgcagtgcaccaactatct, 
cccataactccttgcatttaacatt, and gcttcacctccacacgttta.  
 
Primary hippocampal cultures 
Hippocampal cultures were generated by dissecting the hippocampus from E17.5 embryos in 
wild-type and CPEB2 PD-/- mice. Neurons were plated at 4-6 x 105 cells in 6 well plates with 
25mm glass coverslips pretreated with poly-l-lysine.  Neurons were grown in Neurobasal Media 
containing B27 supplement in a 37 °C, 5% CO2 incubator. Fresh medium was supplemented 
every 2 days after plating. For transfection, wild-type neurons at DIV7-8 were transfected 
CPEB2-EGFP tagged contract or EGFP alone using CalPhos Mammalian Transfection Kit 
following manufactures protocol (Takara USA Biosciences cat. No 631313, Ipswich, 
Massachusetts).  After 24 hours, neurons were immunostaining detailed below.   
 
Immunostaining 
Coverslips with hippocampal neurons were fixed in a 4% paraformaldehyde solution for 10 
minutes at room temperature.  Coverslips were washed with PBS and blocked using 10% goat 
serum in 0.1% Triton PBS.  Following blocking coverslips were incubated with the primary 
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antibody against MAP2K (EMD Millipore Cat No. AB5622) in 0.1% Triton PBS containing 
10% goat serum for overnight.  Following incubation, coverslips were washed three times in 
PBS and incubated with secondary antibody (Alexa Fluor 568 anti-rabbit, Abcam Cat No. 
ab175471) for 24 hours.  Coverslips were washed three times in PBS and mount onto charged 




Brain or tissue culture samples used for western blotting were flash frozen in liquid nitrogen.  
Samples were homogenized with a motorized pestle for 30 seconds using 1mL of TSM lysis 
buffer (10mm Tris-Cl, 100mm NaCl, 30mg MgCl) supplemented with Protease Inhibitor 
Cocktail (Complete Mini, EDTA-Free, Roche Cat No. 1183617001).  All samples and solutions 
were kept on ice.  Unless otherwise noted, lysates were centrifuged at 12,500 rpm for 10 minutes 
at 4ºC, and the supernatant was collected.  The supernatant protein concentration was measured 
using BCA assay (Pierce Biotechnology, Waltham, MA).  4-12% SDS-PAGE gels (Invitrogen 
Cat No. NP0322BOX, Carlsbad, CA) were loaded with 10µg of protein and run in the 
ThermoFisher Scientific XCell Surelock Mini-cell (ThermoFisher Scientific Cat No. EI0002). 
Gels were transferred on PVDF membrane using Trans Blot Turbo transfer apparatus.  
Membranes were blocked with 5% milk in PBS+0.1% Tween-20 at 4ºC.  Primary antibody 
incubation was always performed overnight and secondary antibody incubation was for 1 hour. 
Proteins were assayed by chemiluminescent detection using ECL Western Blotting Substrate 




Semi-denaturing detergent-agarose gel electrophoresis (SDD-AGE)  
For SDD-AGE analysis, the lysates were prepared using western blot protocol above. 
Differently, after determining protein concertation, the lysates the lysates were loaded onto a 
1.5% agarose gel containing 1xTris base, acetic acid (TAE) and 0.1 % SDS.  The gel was run in 
1 x TAE with .1% SDS buffer at 100V, and by gravity transfer, blotted onto PDVF membrane.   
 
Synaptic plasma membrane purification 
Synaptic Plasma Membrane were purified from entire mouse brains from wild-type and CPEB2 
PD-/- mice at 30 days of age (Bermejo, Milenkovic, Salahpour, & Ramsey, 2014).  All of the 
following centrifugations were performed at 4ºC. Lysates were prepared by homogenizing 2 
grams of fresh brain tissue in .32 M HEPES-buffered sucrose solution.  The homogenized 
sample was centrifuged at 900 x g for 10 min and the supernatant was collected (S1).  The pellet 
(P1) contained the nuclear fraction and was collected and stored.  S1 was then centrifuged at 
10,000 x G for 15 minutes and supernatant (S2) was collected and stored. The remaining pellet 
(P2) contained the crude synaptosomal fraction, and was resuspended in 4 ml of 0.32 M HEPE-
buffer sucrose solution.   After an additional 10,000 x g centrifugation for 10 minutes, the 
supernatant was removed (S2’) and the remaining pellet (P2’) was  subjected to hypotonic shock 
by adding 4ml of ddH20 and rotating for 30 minutes at 4ºC.  After hypo-osmotic shock, the P2’ 
fraction was centrifuge at 25,000 x g for 20 minutes at 4 °C. The crude vesicular fraction (S3) 
was removed and the synaptosomal membrane fraction (P3) was resuspended in 1ml of .32M 
HEPES-buffer sucrose solution.  To enrich for the synaptic plasma membrane, the resuspended 
P3 was layered on top of a 1.2M/1.0M/0.8M discontinuous sucrose gradient and ultracentrifuged 
in a swinging bucket rotor SW41 at 150,000 x g for 2 hours.  The interphase between 1.0 M and 
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1.2 M layers was collected and centrifuged again at 150,000 x g for 30 minutes.  The final pellet 
(SPM) contained the synaptic plasma membrane and was resuspended in 300µl of 50 mM 
HEPES / 2 mM EDTA solution and collected for analysis. 
 
Polysome profiling 
For analysis of CPEB2 polysome association, lysates were prepared from brains collected from 3 
months of age wild-type mice.  Brains were homogenized with a motorized pestle for 30 seconds 
using 1mL of TSM lysis buffer (10mm Tris-Cl, 100mm NaCl, 30mg MgCl) supplemented with 
1mm DTT, 200ug/mL cycloheximide, 5ul RNasin, 1% NP40, and Protease Inhibitor Cocktail 
(Complete Mini, EDTA-Free, Roche Cat No. 1183617001). For the EDTA treated lysates, 
EDTA was added to a final concentration of 10mM. Both control and EDTA treated lysates were 
then centrifuged at 12,500 rpm for 10 minutes at 4ºC, and the supernatant was collected.  Using a 
Nanodrop, the total RNA in each lysate was measured by 260nm absorbance (OD260).  Each 
lysate was adjusted to a 20.0 OD260 and 1ml of lysate was layered onto a 7-47% sucrose gradient.  
The control sucrose gradients contained 15mM Tris-Hcl, 140mM NH4Cl4, and 10mM MgOAc. 
The EDTA sucrose gradients contained 15mM Tris-Hcl, 140mM NH4Cl4, 10mM EDTA.  The 
gradients were ultracentrifuged in a swinging bucket rotor at 35,000 x g for 2 hours at 4ºC.   
 
For fractionation and polysome profiling, the gradients were fractioned into 500ul fractions by 
bottom displacement using a Isco fractionator.  The ribosomal profile was continuously 
monitored at OD260 during fractionation.  The fractions were then TCA precipitated and used in 




Antibodies used for western and SDD-AGE  
Primary antibody: GRASP1 antibody polyclonal rabbit IgG (GeneTex Cat No. GTX122295, 
Irvine, California), Fragile X antibody monoclonal mouse IgG (EDM Millipore Cat No. 
MAB2160), SNAP25 antibody monoclonal mouse IgG (BD Biosciences Cat No. 610366), 
CaMKIIa antibody monoclonal mouse IgG (ThermoFisher Cat No. 13-7300), Synaptotagmin 
antibody monoclonal mouse IgG (BD Biosciences Cat No. 610433), phospho-CREB (Ser133) 
Antibody polyclonal rabbit IgG (EDM Millipore Cat No. 06-519), MAP2 antibody polyclonal 
rabbit IgG (EMD Millipore Cat No. AB5622), Actin antibody monoclonal mouse IgG (EMD 
Millipore Cat No. MAB1501), PSD95 antibody monoclonal mouse IgG (ThermoFisher Cat No. 
MA1-046), alpha-tubulin antibody monoclonal mouse (Sigma Cat no. T5168), GluR1 antibody 
monoclonal rabbit IgG (EDM Millipore Cat No. 04-855), rS6 antibody monoclonal mouse 
(Sigma Cat no. 74459). CPEB2 Antibody polyclonal guinea pig affinity purified was raised 
against the purified smallest CPEB2 isoform (CPEB2-204).   CPEB2-204 was induced via IPTG 
induction in pLysS Singles™ Competent Cells. The antibody was affinity purified using the 
purified CPEB2 protein. 
 
Secondary Antibody: Anti-Mouse IgG secondary antibody, HRP conjugated (ThermoFisher Cat 
No. 32430), Anti-Guinea Pig IgG secondary antibody, HRP conjugated (Sigma Cat No. A7289), 






Hippocampal slice preparation: Coronal hippocampal slices (350 µm thick) were obtained from 
both males and females p15-30 and 6-8 months of age WT and CPEB2 PD-/- mice. Mice were 
decapitated and the brain was rapidly extracted and placed in ice-cold artificial cerebrospinal fluid 
(ACSF) that contained (in mM): NaCl 124, KCl 5, NaH2PO4 1.25, MgSO4 2, NaHCO3 26, CaCl2 
2 and glucose 10, and was gassed with 95% O2 / 5% CO2 (pH = 7.3-7.4). Slices were obtained 
with a vibratome (leica VT1200S) and incubated in ACSF at room temperature for at least 1 h 
before use. Then, slices were transferred to an immersion recording chamber, superfused at 2 
ml/min with gassed ACSF and visualized under an Olympus BX50WI microscope (Olympus 
Optical, Japan). Picrotoxin (50 µM) and CGP54626 (1 µM) were added to the bath solution to 
block GABAA and GABAB receptors, respectively.  
 
Electrophysiology: Field excitatory postsynaptic potentials (fEPSP) were recorded from a 
recording pipette placed in the stratum radiatum and filled with ACSF. Signals were obtained with 
a EX-1 amplifier (Dagan Instruments, MN, US) with a 10 KHz sampling rate and filtered with a 3 
Hz low pass filter and a 300 Hz high pass filter. The pCLAMP 10.4 (Axon instruments) software 
was used for stimulus generation, data display, acquisition and storage. fEPSPs were evoked at 
0.33 Hz by stimulating the Schaffer collaterals with a bipolar stimulation electrode placed in the 
stratum radiatum. Input–output relatioships of fEPSPs were made by increasing stimulus 
intensities from 0 to 100 µA. Paired pulses (0.2 ms duration) were applied in the Schaffer 
collaterals with 25, 50, 75, 100, 200, 300 and 500 ms interpulse intervals and the paired-pulse ratio 
was calculated (PPR = 2nd fEPSC slope/ 1st fEPSC slope). For LTP induction a tetanic stimulation 
(4 trains at 100 Hz for 1 s; 30 s intervals) was applied in the Schaffer collaterals. fEPSC slope was 
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normalized to 10 min of baseline recording. The presence of LTP was determined by comparing 
the last 5 min of baseline with the last 5 min of recording. 
 
Open field testing  
For open field testing, mice were housed in their home cages and brought into the testing room 
24 hours prior to the test.  The chamber consisted of a 50cm x 50cm x 50 cm box made of 
transparent plastic.  For the test, a single mouse was placed into the middle of the open field 
arena and allowed to freely roam for 30 minutes.  During the test, a video camera recorded the 
entire duration of the test.  After the trial, the mouse was removed from the arena and the 
apparatus was cleaned with 95% ethanol prior to adding the next subject.  The mouse’s position 
and movement was analyzed using the mouse behavioral software EthoVision XT (Noldus, 
Wageningen, The Netherlands).    
 
Contextual fear conditioning 
For the contextual fear conditioning test mice were housed in their home cages and brought into 
the testing room 24 hours prior to the test.  For this assay 3 months of age wild-type and CPEB2 
PD-/- mice were used. On day 1, mice were placed into the fear conditioning apparatus (a trough-
shaped alley divided between a dark compartment and a light compartment) and permitted to 
explore the apparatus freely. Upon crossing into the dark compartment, a door is inserted to 
confine the mouse to that compartment and inescapable footshocks are delivered (up to two 
footshocks, 1.0 mA intensity, 1 s duration). After the shock, the mouse is removed from the 
apparatus and returned to their home cage.  Retention was tested at the indicated time points by 
returning the mouse to the light compartment with free access to the entire apparatus. The mouse 
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was allowed to freely roam the apparatus for 10 minutes.  The time it took for the mouse to first 
enter to the dark compartment (latency) was recorded by the experimenter.  
 
Morris water maze 
For the contextual fear conditioning test mice were housed in their home cages and brought into 
the testing room 24 hours prior to the test.  For this assay 2-3 months of age wild-type and CPEB2 
PD-/- mice were used. For the training days, the platform was accessible but submerged.  A training 
trial consisted of placing a mouse into the water maze at one of the 4 different starting locations 
(randomized for each day).  The mouse was allowed to freely explore the pool for two minutes, 
when the mouse reached the platform it was removed after 15 seconds. Each training phase 
consisted of 4 trials per day for 3 days.  The probe trial was performed on the 4th and 9th day in the 
water maze with the platform removed.  During the probe trial, the mouse was allowed to freely 
search the pool for 1 minute.  During both the training and probe trials the mouse’s positions and 
movement was recorded by video.  The video was analyzed by using the mouse behavioral 
software EthoVision XT (Noldus).   
 
Statistical analysis 
Data are represented as mean ± standard error of the mean (SEM). Unless otherwise noted: data 
were compared using a two-way ANOVA with Bonferroni post hoc. Statistical differences were 






Appendix 1. PLAAC analysis of CPEB2-4.  (A-C) Top: PLAAC output of longest Cpeb2-4 
isoforms.  Bottom: exon 1 of corresponding gene is aligned to PLAAC output. (A) Cpeb2-204 







Appendix 2.  No change in CaMKIIa expression in 6 - 7 months of age CPEB2 PD-/- mice. 
Whole brain lysates were used in western blots to evaluate levels of CPEB2 target proteins (n=3 
for each target in wild-type and CPEB2 PD-/-. (A) Western blot densitometry analysis shows no 
change in the expression CaMKIIa, between wild-type and CPEB2 PD-/- animals at 6-7 months 






Aakalu, G., Smith, W. B., Nguyen, N., Jiang, C., & Schuman, E. M. (2001). Dynamic 
visualization of local protein synthesis in hippocampal neurons. Neuron, 30(2), 489-502.  
Alarcon, J. M., Hodgman, R., Theis, M., Huang, Y. S., Kandel, E. R., & Richter, J. D. (2004). 
Selective modulation of some forms of schaffer collateral-CA1 synaptic plasticity in mice 
with a disruption of the CPEB-1 gene. Learn Mem, 11(3), 318-327. 
doi:10.1101/lm.72704 
Alberini, C. M., & Kandel, E. R. (2014). The regulation of transcription in memory 
consolidation. Cold Spring Harb Perspect Biol, 7(1), a021741. 
doi:10.1101/cshperspect.a021741 
Alberti, S., Halfmann, R., King, O., Kapila, A., & Lindquist, S. (2009). A systematic survey 
identifies prions and illuminates sequence features of prionogenic proteins. Cell, 137(1), 
146-158. doi:10.1016/j.cell.2009.02.044 
Anderson, P., & Kedersha, N. (2008). Stress granules: the Tao of RNA triage. Trends Biochem 
Sci, 33(3), 141-150. doi:10.1016/j.tibs.2007.12.003 
Bacskai, B. J., Hochner, B., Mahaut-Smith, M., Adams, S. R., Kaang, B. K., Kandel, E. R., & 
Tsien, R. Y. (1993). Spatially resolved dynamics of cAMP and protein kinase A subunits 
in Aplysia sensory neurons. Science, 260(5105), 222-226.  
Bagriantsev, S. N., Kushnirov, V. V., & Liebman, S. W. (2006). Analysis of amyloid aggregates 
using agarose gel electrophoresis. Methods Enzymol, 412, 33-48. doi:10.1016/S0076-
6879(06)12003-0 
Barnard, D. C., Ryan, K., Manley, J. L., & Richter, J. D. (2004). Symplekin and xGLD-2 are 
required for CPEB-mediated cytoplasmic polyadenylation. Cell, 119(5), 641-651. 
doi:10.1016/j.cell.2004.10.029 
Berger-Sweeney, J., Zearfoss, N. R., & Richter, J. D. (2006). Reduced extinction of 
hippocampal-dependent memories in CPEB knockout mice. Learn Mem, 13(1), 4-7. 
doi:10.1101/lm.73706 
Bermejo, M. K., Milenkovic, M., Salahpour, A., & Ramsey, A. J. (2014). Preparation of synaptic 
plasma membrane and postsynaptic density proteins using a discontinuous sucrose 
gradient. J Vis Exp(91), e51896. doi:10.3791/51896 
Boehm, J., Ehrlich, I., Hsieh, H., & Malinow, R. (2006). Two mutations preventing PDZ-protein 
interactions of GluR1 have opposite effects on synaptic plasticity. Learn Mem, 13(5), 
562-565. doi:10.1101/lm.253506 
Buckanovich, R. J., Posner, J. B., & Darnell, R. B. (1993). Nova, the paraneoplastic Ri antigen, 
is homologous to an RNA-binding protein and is specifically expressed in the developing 
motor system. Neuron, 11(4), 657-672.  
Cao, Q., & Richter, J. D. (2002). Dissolution of the maskin-eIF4E complex by cytoplasmic 
polyadenylation and poly(A)-binding protein controls cyclin B1 mRNA translation and 
oocyte maturation. EMBO J, 21(14), 3852-3862. doi:10.1093/emboj/cdf353 
Casadio, A., Martin, K. C., Giustetto, M., Zhu, H., Chen, M., Bartsch, D., . . . Kandel, E. R. 
(1999). A transient, neuron-wide form of CREB-mediated long-term facilitation can be 
stabilized at specific synapses by local protein synthesis. Cell, 99(2), 221-237.  
Chao, H. W., Tsai, L. Y., Lu, Y. L., Lin, P. Y., Huang, W. H., Chou, H. J., . . . Huang, Y. S. 
(2013). Deletion of CPEB3 enhances hippocampus-dependent memory via increasing 
	
	 103	
expressions of PSD95 and NMDA receptors. J Neurosci, 33(43), 17008-17022. 
doi:10.1523/JNEUROSCI.3043-13.2013 
Chasse, H., Boulben, S., Costache, V., Cormier, P., & Morales, J. (2017). Analysis of translation 
using polysome profiling. Nucleic Acids Res, 45(3), e15. doi:10.1093/nar/gkw907 
Chen, P. J., & Huang, Y. S. (2012). CPEB2-eEF2 interaction impedes HIF-1alpha RNA 
translation. EMBO J, 31(4), 959-971. doi:10.1038/emboj.2011.448 
Chen, P. J., Weng, J. Y., Hsu, P. H., Shew, J. Y., Huang, Y. S., & Lee, W. H. (2015). NPGPx 
modulates CPEB2-controlled HIF-1alpha RNA translation in response to oxidative stress. 
Nucleic Acids Res, 43(19), 9393-9404. doi:10.1093/nar/gkv1010 
Crawley, J. N. (2008). Behavioral phenotyping strategies for mutant mice. Neuron, 57(6), 809-
818. doi:10.1016/j.neuron.2008.03.001 
Curzon, P., Rustay, N. R., & Browman, K. E. (2009). Cued and Contextual Fear Conditioning 
for Rodents. In nd & J. J. Buccafusco (Eds.), Methods of Behavior Analysis in 
Neuroscience. Boca Raton (FL). 
Darnell, J. C., Van Driesche, S. J., Zhang, C., Hung, K. Y., Mele, A., Fraser, C. E., . . . Darnell, 
R. B. (2011). FMRP stalls ribosomal translocation on mRNAs linked to synaptic function 
and autism. Cell, 146(2), 247-261. doi:10.1016/j.cell.2011.06.013 
Derkatch, I. L., Bradley, M. E., Zhou, P., Chernoff, Y. O., & Liebman, S. W. (1997). Genetic 
and environmental factors affecting the de novo appearance of the [PSI+] prion in 
Saccharomyces cerevisiae. Genetics, 147(2), 507-519.  
Derkatch, I. L., Chernoff, Y. O., Kushnirov, V. V., Inge-Vechtomov, S. G., & Liebman, S. W. 
(1996). Genesis and variability of [PSI] prion factors in Saccharomyces cerevisiae. 
Genetics, 144(4), 1375-1386.  
Drisaldi, B., Colnaghi, L., Fioriti, L., Rao, N., Myers, C., Snyder, A. M., . . . Kandel, E. R. 
(2015). SUMOylation Is an Inhibitory Constraint that Regulates the Prion-like 
Aggregation and Activity of CPEB3. Cell Rep, 11(11), 1694-1702. 
doi:10.1016/j.celrep.2015.04.061 
Ebbinghaus, H. (1885). Über das Gedächtnis. Untersuchungen zur experimentellen Psychologie. 
Leipzig,: Duncker & Humblot. 
Fass, B., & Steward, O. (1983). Increases in protein-precursor incorporation in the denervated 
neuropil of the dentate gyrus during reinnervation. Neuroscience, 9(3), 653-664.  
Fioravante, D., & Regehr, W. G. (2011). Short-term forms of presynaptic plasticity. Curr Opin 
Neurobiol, 21(2), 269-274. doi:10.1016/j.conb.2011.02.003 
Fioriti, L., Myers, C., Huang, Y. Y., Li, X., Stephan, J. S., Trifilieff, P., . . . Kandel, E. R. (2015). 
The Persistence of Hippocampal-Based Memory Requires Protein Synthesis Mediated by 
the Prion-like Protein CPEB3. Neuron, 86(6), 1433-1448. 
doi:10.1016/j.neuron.2015.05.021 
Fisher, S. A., Fischer, T. M., & Carew, T. J. (1997). Multiple overlapping processes underlying 
short-term synaptic enhancement. Trends Neurosci, 20(4), 170-177.  
Flexner, J. B., Flexner, L. B., & Stellar, E. (1963). Memory in mice as affected by intracerebral 
puromycin. Science, 141(3575), 57-59.  
Fortune, E. S., & Rose, G. J. (2001). Short-term synaptic plasticity as a temporal filter. Trends 
Neurosci, 24(7), 381-385.  
Frey, S., Morris, R., & Petrides, M. (1997). A neuroanatomical method to assess the integrity of 
fibers of passage following ibotenate-induced damage to the central nervous system. 
Neurosci Res, 28(3), 285-288.  
	
	 104	
Frey, U., Krug, M., Reymann, K. G., & Matthies, H. (1988). Anisomycin, an inhibitor of protein 
synthesis, blocks late phases of LTP phenomena in the hippocampal CA1 region in vitro. 
Brain Res, 452(1-2), 57-65.  
Frey, U., & Morris, R. G. (1997). Synaptic tagging and long-term potentiation. Nature, 
385(6616), 533-536. doi:10.1038/385533a0 
Ganusova, E. E., Ozolins, L. N., Bhagat, S., Newnam, G. P., Wegrzyn, R. D., Sherman, M. Y., & 
Chernoff, Y. O. (2006). Modulation of prion formation, aggregation, and toxicity by the 
actin cytoskeleton in yeast. Mol Cell Biol, 26(2), 617-629. doi:10.1128/MCB.26.2.617-
629.2006 
Giese, K. P., Fedorov, N. B., Filipkowski, R. K., & Silva, A. J. (1998). Autophosphorylation at 
Thr286 of the alpha calcium-calmodulin kinase II in LTP and learning. Science, 
279(5352), 870-873.  
Golding, G. B. (1999). Simple sequence is abundant in eukaryotic proteins. Protein Sci, 8(6), 
1358-1361. doi:10.1110/ps.8.6.1358 
Hagele, S., Kuhn, U., Boning, M., & Katschinski, D. M. (2009). Cytoplasmic polyadenylation-
element-binding protein (CPEB)1 and 2 bind to the HIF-1alpha mRNA 3'-UTR and 
modulate HIF-1alpha protein expression. Biochem J, 417(1), 235-246. 
doi:10.1042/BJ20081353 
Harrison, A. F., & Shorter, J. (2017). RNA-binding proteins with prion-like domains in health 
and disease. Biochem J, 474(8), 1417-1438. doi:10.1042/BCJ20160499 
Hitzemann, R. (2000). Animal models of psychiatric disorders and their relevance to alcoholism. 
Alcohol Res Health, 24(3), 149-158.  
Hitzemann, R., Darakjian, P., Walter, N., Iancu, O. D., Searles, R., & McWeeney, S. (2014). 
Introduction to sequencing the brain transcriptome. Int Rev Neurobiol, 116, 1-19. 
doi:10.1016/B978-0-12-801105-8.00001-1 
Hoogenraad, C. C., Popa, I., Futai, K., Martinez-Sanchez, E., Wulf, P. S., van Vlijmen, T., . . . 
van der Sluijs, P. (2010). Neuron specific Rab4 effector GRASP-1 coordinates membrane 
specialization and maturation of recycling endosomes. PLoS Biol, 8(1), e1000283. 
doi:10.1371/journal.pbio.1000283 
Huang, Y. S., Jung, M. Y., Sarkissian, M., & Richter, J. D. (2002). N-methyl-D-aspartate 
receptor signaling results in Aurora kinase-catalyzed CPEB phosphorylation and alpha 
CaMKII mRNA polyadenylation at synapses. EMBO J, 21(9), 2139-2148. 
doi:10.1093/emboj/21.9.2139 
Huang, Y. S., Kan, M. C., Lin, C. L., & Richter, J. D. (2006). CPEB3 and CPEB4 in neurons: 
analysis of RNA-binding specificity and translational control of AMPA receptor GluR2 
mRNA. EMBO J, 25(20), 4865-4876. doi:10.1038/sj.emboj.7601322 
Huff, M. L., Emmons, E. B., Narayanan, N. S., & LaLumiere, R. T. (2016). Basolateral 
amygdala projections to ventral hippocampus modulate the consolidation of footshock, 
but not contextual, learning in rats. Learn Mem, 23(2), 51-60. doi:10.1101/lm.039909.115 
Jensen, K. B., Dredge, B. K., Stefani, G., Zhong, R., Buckanovich, R. J., Okano, H. J., . . . 
Darnell, R. B. (2000). Nova-1 regulates neuron-specific alternative splicing and is 
essential for neuronal viability. Neuron, 25(2), 359-371.  
Kaech, S., & Banker, G. (2006). Culturing hippocampal neurons. Nat Protoc, 1(5), 2406-2415. 
doi:10.1038/nprot.2006.356 
Kandel, E. R., Dudai, Y., & Mayford, M. R. (2014). The molecular and systems biology of 
memory. Cell, 157(1), 163-186. doi:10.1016/j.cell.2014.03.001 
	
	 105	
Kang, H., & Schuman, E. M. (1996). A requirement for local protein synthesis in neurotrophin-
induced hippocampal synaptic plasticity. Science, 273(5280), 1402-1406.  
Keleman, K., Kruttner, S., Alenius, M., & Dickson, B. J. (2007). Function of the Drosophila 
CPEB protein Orb2 in long-term courtship memory. Nat Neurosci, 10(12), 1587-1593. 
doi:10.1038/nn1996 
Kelleher, R. J., 3rd, Govindarajan, A., & Tonegawa, S. (2004). Translational regulatory 
mechanisms in persistent forms of synaptic plasticity. Neuron, 44(1), 59-73. 
doi:10.1016/j.neuron.2004.09.013 
Khan, M. R., Li, L., Perez-Sanchez, C., Saraf, A., Florens, L., Slaughter, B. D., . . . Si, K. (2015). 
Amyloidogenic Oligomerization Transforms Drosophila Orb2 from a Translation 
Repressor to an Activator. Cell, 163(6), 1468-1483. doi:10.1016/j.cell.2015.11.020 
Kim, H. J., Kim, N. C., Wang, Y. D., Scarborough, E. A., Moore, J., Diaz, Z., . . . Taylor, J. P. 
(2013). Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause 
multisystem proteinopathy and ALS. Nature, 495(7442), 467-473. 
doi:10.1038/nature11922 
Kim, J. H., & Richter, J. D. (2006). Opposing polymerase-deadenylase activities regulate 
cytoplasmic polyadenylation. Mol Cell, 24(2), 173-183. 
doi:10.1016/j.molcel.2006.08.016 
King, O. D., Gitler, A. D., & Shorter, J. (2012). The tip of the iceberg: RNA-binding proteins 
with prion-like domains in neurodegenerative disease. Brain Res, 1462, 61-80. 
doi:10.1016/j.brainres.2012.01.016 
Krug, M., Lossner, B., & Ott, T. (1984). Anisomycin blocks the late phase of long-term 
potentiation in the dentate gyrus of freely moving rats. Brain Res Bull, 13(1), 39-42.  
Kruttner, S., Stepien, B., Noordermeer, J. N., Mommaas, M. A., Mechtler, K., Dickson, B. J., & 
Keleman, K. (2012). Drosophila CPEB Orb2A mediates memory independent of Its 
RNA-binding domain. Neuron, 76(2), 383-395. doi:10.1016/j.neuron.2012.08.028 
Kryndushkin, D. S., Alexandrov, I. M., Ter-Avanesyan, M. D., & Kushnirov, V. V. (2003). 
Yeast [PSI+] prion aggregates are formed by small Sup35 polymers fragmented by 
Hsp104. J Biol Chem, 278(49), 49636-49643. doi:10.1074/jbc.M307996200 
Kumar, A. (2011). Long-Term Potentiation at CA3-CA1 Hippocampal Synapses with Special 
Emphasis on Aging, Disease, and Stress. Front Aging Neurosci, 3, 7. 
doi:10.3389/fnagi.2011.00007 
Kurihara, Y., Tokuriki, M., Myojin, R., Hori, T., Kuroiwa, A., Matsuda, Y., . . . Uesugi, S. 
(2003). CPEB2, a novel putative translational regulator in mouse haploid germ cells. Biol 
Reprod, 69(1), 261-268. doi:10.1095/biolreprod.103.015677 
Lai, Y. T., Su, C. K., Jiang, S. T., Chang, Y. J., Lai, A. C., & Huang, Y. S. (2016). Deficiency of 
CPEB2-Confined Choline Acetyltransferase Expression in the Dorsal Motor Nucleus of 
Vagus Causes Hyperactivated Parasympathetic Signaling-Associated 
Bronchoconstriction. J Neurosci, 36(50), 12661-12676. doi:10.1523/JNEUROSCI.0557-
16.2016 
Lancaster, A. K., Nutter-Upham, A., Lindquist, S., & King, O. D. (2014). PLAAC: a web and 
command-line application to identify proteins with prion-like amino acid composition. 
Bioinformatics, 30(17), 2501-2502. doi:10.1093/bioinformatics/btu310 
Li, L., & Lindquist, S. (2000). Creating a protein-based element of inheritance. Science, 
287(5453), 661-664.  
	
	 106	
Li, L., Sanchez, C. P., Slaughter, B. D., Zhao, Y., Khan, M. R., Unruh, J. R., . . . Si, K. (2016). A 
Putative Biochemical Engram of Long-Term Memory. Curr Biol, 26(23), 3143-3156. 
doi:10.1016/j.cub.2016.09.054 
Li, Y. R., King, O. D., Shorter, J., & Gitler, A. D. (2013). Stress granules as crucibles of ALS 
pathogenesis. J Cell Biol, 201(3), 361-372. doi:10.1083/jcb.201302044 
Lin, C. L., Evans, V., Shen, S., Xing, Y., & Richter, J. D. (2010). The nuclear experience of 
CPEB: implications for RNA processing and translational control. RNA, 16(2), 338-348. 
doi:10.1261/rna.1779810 
Lisman, J., Malenka, R. C., Nicoll, R. A., & Malinow, R. (1997). Learning mechanisms: the case 
for CaM-KII. Science, 276(5321), 2001-2002.  
Lu, W. H., Yeh, N. H., & Huang, Y. S. (2017). CPEB2 Activates GRASP1 mRNA Translation 
and Promotes AMPA Receptor Surface Expression, Long-Term Potentiation, and 
Memory. Cell Rep, 21(7), 1783-1794. doi:10.1016/j.celrep.2017.10.073 
Mahmoud, G. S., & Grover, L. M. (2006). Growth hormone enhances excitatory synaptic 
transmission in area CA1 of rat hippocampus. J Neurophysiol, 95(5), 2962-2974. 
doi:10.1152/jn.00947.2005 
Majumdar, A., Cesario, W. C., White-Grindley, E., Jiang, H., Ren, F., Khan, M. R., . . . Si, K. 
(2012). Critical role of amyloid-like oligomers of Drosophila Orb2 in the persistence of 
memory. Cell, 148(3), 515-529. doi:10.1016/j.cell.2012.01.004 
Maletic-Savatic, M., Koothan, T., & Malinow, R. (1998). Calcium-evoked dendritic exocytosis 
in cultured hippocampal neurons. Part II: mediation by calcium/calmodulin-dependent 
protein kinase II. J Neurosci, 18(17), 6814-6821.  
Martin, K. C., Casadio, A., Zhu, H., Yaping, E., Rose, J. C., Chen, M., . . . Kandel, E. R. (1997). 
Synapse-specific, long-term facilitation of aplysia sensory to motor synapses: a function 
for local protein synthesis in memory storage. Cell, 91(7), 927-938.  
Martin, K. C., Michael, D., Rose, J. C., Barad, M., Casadio, A., Zhu, H., & Kandel, E. R. (1997). 
MAP kinase translocates into the nucleus of the presynaptic cell and is required for long-
term facilitation in Aplysia. Neuron, 18(6), 899-912.  
Mastushita-Sakai, T., White-Grindley, E., Samuelson, J., Seidel, C., & Si, K. (2010). Drosophila 
Orb2 targets genes involved in neuronal growth, synapse formation, and protein turnover. 
Proc Natl Acad Sci U S A, 107(26), 11987-11992. doi:10.1073/pnas.1004433107 
Mathur, V., Taneja, V., Sun, Y., & Liebman, S. W. (2010). Analyzing the birth and propagation 
of two distinct prions, [PSI+] and [Het-s](y), in yeast. Mol Biol Cell, 21(9), 1449-1461. 
doi:10.1091/mbc.E09-11-0927 
Matilla, A., Roberson, E. D., Banfi, S., Morales, J., Armstrong, D. L., Burright, E. N., . . . 
Matzuk, M. M. (1998). Mice lacking ataxin-1 display learning deficits and decreased 
hippocampal paired-pulse facilitation. J Neurosci, 18(14), 5508-5516.  
Mayford, M., Siegelbaum, S. A., & Kandel, E. R. (2012). Synapses and memory storage. Cold 
Spring Harb Perspect Biol, 4(6). doi:10.1101/cshperspect.a005751 
McGrew, L. L., Dworkin-Rastl, E., Dworkin, M. B., & Richter, J. D. (1989). Poly(A) elongation 
during Xenopus oocyte maturation is required for translational recruitment and is 
mediated by a short sequence element. Genes Dev, 3(6), 803-815.  
Meiri, N., Sun, M. K., Segal, Z., & Alkon, D. L. (1998). Memory and long-term potentiation 
(LTP) dissociated: normal spatial memory despite CA1 LTP elimination with Kv1.4 
antisense. Proc Natl Acad Sci U S A, 95(25), 15037-15042.  
	
	 107	
Mendez, R., Murthy, K. G., Ryan, K., Manley, J. L., & Richter, J. D. (2000). Phosphorylation of 
CPEB by Eg2 mediates the recruitment of CPSF into an active cytoplasmic 
polyadenylation complex. Mol Cell, 6(5), 1253-1259.  
Michelitsch, M. D., & Weissman, J. S. (2000). A census of glutamine/asparagine-rich regions: 
implications for their conserved function and the prediction of novel prions. Proc Natl 
Acad Sci U S A, 97(22), 11910-11915. doi:10.1073/pnas.97.22.11910 
Miller, S., Yasuda, M., Coats, J. K., Jones, Y., Martone, M. E., & Mayford, M. (2002). 
Disruption of dendritic translation of CaMKIIalpha impairs stabilization of synaptic 
plasticity and memory consolidation. Neuron, 36(3), 507-519.  
Miniaci, M. C., Kim, J. H., Puthanveettil, S. V., Si, K., Zhu, H., Kandel, E. R., & Bailey, C. H. 
(2008). Sustained CPEB-dependent local protein synthesis is required to stabilize 
synaptic growth for persistence of long-term facilitation in Aplysia. Neuron, 59(6), 1024-
1036. doi:10.1016/j.neuron.2008.07.036 
Minshall, N., Reiter, M. H., Weil, D., & Standart, N. (2007). CPEB interacts with an ovary-
specific eIF4E and 4E-T in early Xenopus oocytes. J Biol Chem, 282(52), 37389-37401. 
doi:10.1074/jbc.M704629200 
Miyamoto, E. (2006). Molecular mechanism of neuronal plasticity: induction and maintenance of 
long-term potentiation in the hippocampus. J Pharmacol Sci, 100(5), 433-442.  
Montkowski, A., & Holsboer, F. (1997). Intact spatial learning and memory in transgenic mice 
with reduced BDNF. Neuroreport, 8(3), 779-782.  
Morris, R. (1984). Developments of a water-maze procedure for studying spatial learning in the 
rat. J Neurosci Methods, 11(1), 47-60.  
Nakazawa, K., Quirk, M. C., Chitwood, R. A., Watanabe, M., Yeckel, M. F., Sun, L. D., . . . 
Tonegawa, S. (2002). Requirement for hippocampal CA3 NMDA receptors in associative 
memory recall. Science, 297(5579), 211-218. doi:10.1126/science.1071795 
Novoa, I., Gallego, J., Ferreira, P. G., & Mendez, R. (2010). Mitotic cell-cycle progression is 
regulated by CPEB1 and CPEB4-dependent translational control. Nat Cell Biol, 12(5), 
447-456. doi:10.1038/ncb2046 
Oesch, B., Westaway, D., Walchli, M., McKinley, M. P., Kent, S. B., Aebersold, R., . . . et al. 
(1985). A cellular gene encodes scrapie PrP 27-30 protein. Cell, 40(4), 735-746.  
Pan, K. M., Baldwin, M., Nguyen, J., Gasset, M., Serban, A., Groth, D., . . . et al. (1993). 
Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion 
proteins. Proc Natl Acad Sci U S A, 90(23), 10962-10966.  
Pavlopoulos, E., Trifilieff, P., Chevaleyre, V., Fioriti, L., Zairis, S., Pagano, A., . . . Kandel, E. R. 
(2011). Neuralized1 activates CPEB3: a function for nonproteolytic ubiquitin in synaptic 
plasticity and memory storage. Cell, 147(6), 1369-1383. doi:10.1016/j.cell.2011.09.056 
Phillips, R. G., & LeDoux, J. E. (1992). Differential contribution of amygdala and hippocampus 
to cued and contextual fear conditioning. Behav Neurosci, 106(2), 274-285.  
Pique, M., Lopez, J. M., Foissac, S., Guigo, R., & Mendez, R. (2008). A combinatorial code for 
CPE-mediated translational control. Cell, 132(3), 434-448. 
doi:10.1016/j.cell.2007.12.038 
Post, A. M., Weyers, P., Holzer, P., Painsipp, E., Pauli, P., Wultsch, T., . . . Lesch, K. P. (2011). 
Gene-environment interaction influences anxiety-like behavior in ethologically based 
mouse models. Behav Brain Res, 218(1), 99-105. doi:10.1016/j.bbr.2010.11.031 
Prusiner, S. B. (1982). Novel proteinaceous infectious particles cause scrapie. Science, 
216(4542), 136-144.  
	
	 108	
Prusiner, S. B. (1998). Prions. Proc Natl Acad Sci U S A, 95(23), 13363-13383.  
Raveendra, B. L., Siemer, A. B., Puthanveettil, S. V., Hendrickson, W. A., Kandel, E. R., & 
McDermott, A. E. (2013). Characterization of prion-like conformational changes of the 
neuronal isoform of Aplysia CPEB. Nat Struct Mol Biol, 20(4), 495-501. 
doi:10.1038/nsmb.2503 
Richter, J. D. (1999). Cytoplasmic polyadenylation in development and beyond. Microbiol Mol 
Biol Rev, 63(2), 446-456.  
Rizzoli, S. O., & Betz, W. J. (2005). Synaptic vesicle pools. Nat Rev Neurosci, 6(1), 57-69. 
doi:10.1038/nrn1583 
Rozov, A., & Burnashev, N. (1999). Polyamine-dependent facilitation of postsynaptic AMPA 
receptors counteracts paired-pulse depression. Nature, 401(6753), 594-598. 
doi:10.1038/44151 
Rozov, A., Zilberter, Y., Wollmuth, L. P., & Burnashev, N. (1998). Facilitation of currents 
through rat Ca2+-permeable AMPA receptor channels by activity-dependent relief from 
polyamine block. J Physiol, 511 ( Pt 2), 361-377.  
Sachs, A. B., Sarnow, P., & Hentze, M. W. (1997). Starting at the beginning, middle, and end: 
translation initiation in eukaryotes. Cell, 89(6), 831-838.  
Salles, F. J., Lieberfarb, M. E., Wreden, C., Gergen, J. P., & Strickland, S. (1994). Coordinate 
initiation of Drosophila development by regulated polyadenylation of maternal 
messenger RNAs. Science, 266(5193), 1996-1999.  
Shin, J., Salameh, J. S., & Richter, J. D. (2016). Impaired neurodevelopment by the low 
complexity domain of CPEB4 reveals a convergent pathway with neurodegeneration. Sci 
Rep, 6, 29395. doi:10.1038/srep29395 
Si, K., Choi, Y. B., White-Grindley, E., Majumdar, A., & Kandel, E. R. (2010). Aplysia CPEB 
can form prion-like multimers in sensory neurons that contribute to long-term facilitation. 
Cell, 140(3), 421-435. doi:10.1016/j.cell.2010.01.008 
Si, K., Giustetto, M., Etkin, A., Hsu, R., Janisiewicz, A. M., Miniaci, M. C., . . . Kandel, E. R. 
(2003). A neuronal isoform of CPEB regulates local protein synthesis and stabilizes 
synapse-specific long-term facilitation in aplysia. Cell, 115(7), 893-904.  
Si, K., Lindquist, S., & Kandel, E. R. (2003). A neuronal isoform of the aplysia CPEB has prion-
like properties. Cell, 115(7), 879-891.  
Silva, A. J., Rosahl, T. W., Chapman, P. F., Marowitz, Z., Friedman, E., Frankland, P. W., . . . 
Bourtchuladze, R. (1996). Impaired learning in mice with abnormal short-lived plasticity. 
Curr Biol, 6(11), 1509-1518.  
Silva, A. J., Stevens, C. F., Tonegawa, S., & Wang, Y. (1992). Deficient hippocampal long-term 
potentiation in alpha-calcium-calmodulin kinase II mutant mice. Science, 257(5067), 
201-206.  
Stebbins-Boaz, B., Cao, Q., de Moor, C. H., Mendez, R., & Richter, J. D. (1999). Maskin is a 
CPEB-associated factor that transiently interacts with elF-4E. Mol Cell, 4(6), 1017-1027.  
Stephan, J. S., Fioriti, L., Lamba, N., Colnaghi, L., Karl, K., Derkatch, I. L., & Kandel, E. R. 
(2015). The CPEB3 Protein Is a Functional Prion that Interacts with the Actin 
Cytoskeleton. Cell Rep, 11(11), 1772-1785. doi:10.1016/j.celrep.2015.04.060 
Steward, O., & Fass, B. (1983). Polyribosomes associated with dendritic spines in the denervated 
dentate gyrus: evidence for local regulation of protein synthesis during reinnervation. 
Prog Brain Res, 58, 131-136. doi:10.1016/S0079-6123(08)60013-8 
	
	 109	
Steward, O., & Levy, W. B. (1982). Preferential localization of polyribosomes under the base of 
dendritic spines in granule cells of the dentate gyrus. J Neurosci, 2(3), 284-291.  
Tayler, K. K., Tanaka, K. Z., Reijmers, L. G., & Wiltgen, B. J. (2013). Reactivation of neural 
ensembles during the retrieval of recent and remote memory. Curr Biol, 23(2), 99-106. 
doi:10.1016/j.cub.2012.11.019 
Telling, G. C., Parchi, P., DeArmond, S. J., Cortelli, P., Montagna, P., Gabizon, R., . . . Prusiner, 
S. B. (1996). Evidence for the conformation of the pathologic isoform of the prion 
protein enciphering and propagating prion diversity. Science, 274(5295), 2079-2082.  
Theis, M., Si, K., & Kandel, E. R. (2003). Two previously undescribed members of the mouse 
CPEB family of genes and their inducible expression in the principal cell layers of the 
hippocampus. Proc Natl Acad Sci U S A, 100(16), 9602-9607. 
doi:10.1073/pnas.1133424100 
Tsai, L. Y., Chang, Y. W., Lin, P. Y., Chou, H. J., Liu, T. J., Lee, P. T., . . . Huang, Y. S. (2013). 
CPEB4 knockout mice exhibit normal hippocampus-related synaptic plasticity and 
memory. PLoS One, 8(12), e84978. doi:10.1371/journal.pone.0084978 
Turimella, S. L., Bedner, P., Skubal, M., Vangoor, V. R., Kaczmarczyk, L., Karl, K., . . . Theis, 
M. (2015). Characterization of cytoplasmic polyadenylation element binding 2 protein 
expression and its RNA binding activity. Hippocampus, 25(5), 630-642. 
doi:10.1002/hipo.22399 
Ule, J., Stefani, G., Mele, A., Ruggiu, M., Wang, X., Taneri, B., . . . Darnell, R. B. (2006). An 
RNA map predicting Nova-dependent splicing regulation. Nature, 444(7119), 580-586. 
doi:10.1038/nature05304 
Villalba, A., Coll, O., & Gebauer, F. (2011). Cytoplasmic polyadenylation and translational 
control. Curr Opin Genet Dev, 21(4), 452-457. doi:10.1016/j.gde.2011.04.006 
Vorhees, C. V., & Williams, M. T. (2006). Morris water maze: procedures for assessing spatial 
and related forms of learning and memory. Nat Protoc, 1(2), 848-858. 
doi:10.1038/nprot.2006.116 
Wang, H., Shimizu, E., Tang, Y. P., Cho, M., Kyin, M., Zuo, W., . . . Tsien, J. Z. (2003). 
Inducible protein knockout reveals temporal requirement of CaMKII reactivation for 
memory consolidation in the brain. Proc Natl Acad Sci U S A, 100(7), 4287-4292. 
doi:10.1073/pnas.0636870100 
Wehner, J. M., & Radcliffe, R. A. (2004). Cued and contextual fear conditioning in mice. Curr 
Protoc Neurosci, Chapter 8, Unit 8 5C. doi:10.1002/0471142301.ns0805cs27 
West, A. E., Griffith, E. C., & Greenberg, M. E. (2002). Regulation of transcription factors by 
neuronal activity. Nat Rev Neurosci, 3(12), 921-931. doi:10.1038/nrn987 
Whittaker, V. P. (1993). Thirty years of synaptosome research. J Neurocytol, 22(9), 735-742.  
Whittaker, V. P., Michaelson, I. A., & Kirkland, R. J. (1964). The separation of synaptic vesicles 
from nerve-ending particles ('synaptosomes'). Biochem J, 90(2), 293-303.  
Wootton, J. C., & Federhen, S. (1996). Analysis of compositionally biased regions in sequence 
databases. Methods Enzymol, 266, 554-571.  
Wu, L., Wells, D., Tay, J., Mendis, D., Abbott, M. A., Barnitt, A., . . . Richter, J. D. (1998). 
CPEB-mediated cytoplasmic polyadenylation and the regulation of experience-dependent 
translation of alpha-CaMKII mRNA at synapses. Neuron, 21(5), 1129-1139.  
Wu, L. G., & Saggau, P. (1994). Presynaptic calcium is increased during normal synaptic 
transmission and paired-pulse facilitation, but not in long-term potentiation in area CA1 
of hippocampus. J Neurosci, 14(2), 645-654.  
	
	 110	
Zamanillo, D., Sprengel, R., Hvalby, O., Jensen, V., Burnashev, N., Rozov, A., . . . Sakmann, B. 
(1999). Importance of AMPA receptors for hippocampal synaptic plasticity but not for 
spatial learning. Science, 284(5421), 1805-1811.  
Zearfoss, N. R., Alarcon, J. M., Trifilieff, P., Kandel, E., & Richter, J. D. (2008). A molecular 
circuit composed of CPEB-1 and c-Jun controls growth hormone-mediated synaptic 
plasticity in the mouse hippocampus. J Neurosci, 28(34), 8502-8509. 
doi:10.1523/JNEUROSCI.1756-08.2008 
Zucker, R. S., & Regehr, W. G. (2002). Short-term synaptic plasticity. Annu Rev Physiol, 64, 
355-405. doi:10.1146/annurev.physiol.64.092501.114547 
  
